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Abstract 
 
Factors influencing the decentralisation of Multi-Drug Resistant Tuberculosis care: a 
management perspective. 
K. A. Mekler 
A mini-thesis submitted in partial fulfilment of the requirements for the degree of Master in 
Public Health at the School of Public Health, University of the Western Cape. 
Decentralisation of multi-drug resistant tuberculosis (MDR-TB) services has resulted in 
improved access to care, with community-based treatment of MDR-TB shown to be more 
effective than centralised hospital-based care. Furthermore, increasing bed shortages resulted 
in the National Department of Health establishing MDR-TB policy guidelines in 2011. 
However, the extent to which this policy has been implemented by the decentralised MDR- 
TB sites and the factors influencing implementation of the policy from a management 
perspective were not well described. 
The aim of this study was therefore to explore and compare the actual and ascribed roles and 
responsibilities of key management-level role players at the decentralised MDR-TB sites, and 
to explore the factors influencing implementation of the MDR-TB decentralisation policy 
(2011). 
This study used a qualitative design to explore the experiences of the managers in the 
implementation of the MDR-TB decentralisation policy. Purposive sampling was used to 
select participants. In total, eighteen participants were interviewed. 
There were sixteen participants within the peripheral tier of management, the decentralised 
site management team (DSMT), and two participants within the district tier of management, 
the district health management team (DHMT). A thematic coding approach was used to 
analyse the data. 
Findings showed that despite a similarity between the actual and ascribed roles of the role 
players, there was a mismatch between practice and policy in terms of roles and 
responsibilities. The study found that traditional roles and responsibilities were hindered due 
to lack of availability of the complement of staff to support a multi-disciplinary approach. 
Furthermore, there was an expectation to take on additional responsibilities over and above 
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the responsibilities of that particular role player. Factors influencing implementation of the 
MDR-TB decentralisation policy included operational constraints, such as administration of 
daily injections to ambulatory patients. Health system factors included poor alignment of 
NGOs to governmental services, lack of integration of TB and HIV services, and lack of 
communication between different levels of care. Health care provider-related factors included 
staff shortages, poor staff morale, and fear of contracting TB. Lastly, patient-related factors 
included Lost to Follow Up, stigma, and social grants of MDR-TB patients. 
The study concluded that there is a mismatch between the actual and ascribed roles and 
responsibilities of key role players in implementation of the MDR-TB decentralisation policy 
(2011), with additional responsibilities expected of staff. In addition, implementation of the 
policy is influenced by numerous provider- and patient-related factors. Recommendations 
included staff recruitment for vacant posts and retention strategies be improved and that inter- 
sectoral platforms to ensure that NGO support, aligned to the needs of the programme, should 
be strengthened. Efforts to integrate TB and HIV services at all points of care should be 
encouraged. Furthermore, communication of data should be available through inter-operable 
systems between primary health care (PHC) clinics and decentralised sites. Lastly, training on 
MDR-TB at PHC level and stigma reduction training at community level should be 
strengthened.
http://etd.uwc.ac.za/
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1. INTRODUCTION 
 
Tuberculosis (TB) remains the biggest infectious disease killer worldwide (Dheda et al, 2018). 
Drug-resistant TB (DR-TB) is an emerging threat globally, with an estimated 600,000 cases of 
multidrug-resistant TB (MDR-TB) in 2016, and 490,000 cases of confirmed multidrug- 
resistant TB (MDR-TB) diagnosed in 2016. In addition, 110,000 cases were susceptible to 
isoniazid but resistant to rifampicin (RR-TB), thus managed programmatically as MDR-TB 
(Global Tuberculosis Report, 2017). 
Data compiled from surveys and ongoing surveillance of drug resistance among TB patients 
also allow estimation of the number of MDR-TB cases among notified TB patients with 
pulmonary TB. These are the MDR-TB cases that could be detected if all notified patients were 
tested for drug resistance to the most effective first line drugs, rifampicin and isoniazid, using 
WHO-recommended diagnostic tests. Globally in 2016, there were an estimated 350,000 
multidrug-resistant/rifampicin-resistant (MDR/RR-TB) cases among notified TB patients 
(Global Tuberculosis Report, 2017). 
Furthermore, according to the Global Tuberculosis Report (2017) only 85 % of the 153,119 
MDR/RR-TB patients notified in 2016 were actually started on MDR-TB treatment, indicating 
that case detection is advancing faster than the capacity to link diagnosed patients to care and 
provide treatment. 
In terms of treatment success, the most recently published WHO report reflects data of the 2014 
cohort who completed the required twenty-four months of treatment showed a cure rate of only 
54 % and approximately 240,000 deaths from MDR/RR-TB in 2016 (Global Tuberculosis 
Report, 2017). Evidence suggests that despite treatment, multidrug-resistant strains of 
tuberculosis substantially increase the risk of death when compared to drug-susceptible TB 
even after adjusting for various confounders (Chung- Delgado et al, 2015). In addition, the 
costs of treating drug-resistant TB are significantly higher (US$2,000-20,000 per patient) than 
drug-susceptible TB (US$100-1,000 per patient), with funding for MDR-TB reaching US$1.7 
billion in 2017 (Global Tuberculosis Report 2017).  
Globally there is increasing evidence in several MDR-TB programmes of improved access to 
care and management through decentralisation, without compromising treatment outcomes 
(Cox & Ford, 2013). Improved treatment outcomes in a decentralised MDR-TB model of care 
have been demonstrated. For example, in Peru, improved treatment outcomes were 
http://etd.uwc.ac.za/
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documented with a cohort of 1,000 MDR-TB patients managed through a decentralised model 
of care using NGO support (Shin et al, 2004). Another example of improved TB health outcome 
is in the case of Nepal where a cure rate of 70 % among MDR-TB patients who were treated 
through ambulatory care was documented (Malla et al, 2009). Finally, a systematic review 
revealed that a community-based treatment model versus traditional hospitalisation for 
improving treatment success rates among MDR-TB patients showed that community-based 
treatment achieved a higher treatment success rate and a lower treatment failure rate according 
to sixteen studies involving 3,344 patients from nine countries (Williams, 2016). 
 
1.1 South Africa and decentralising MDR-TB 
In South Africa, the burden of MDR-TB disease is concerning. In 2016, there were an 
estimated 8,200 MDR/RR-TB cases among notified pulmonary TB cases in South Africa, 
with 19,073 laboratory-confirmed cases MDR/RR-TB cases. Of the 11,192 patients started on 
treatment,  a success rate (the sum of cure and completion rates) of 54 % was achieved 
(Global Tuberculosis Report, 2017). Furthermore, drug-resistant TB is complex and costly to 
treat, with almost 40 % of all TB resources in South Africa spent on managing and 
controlling drug-resistant TB (Dheda et al, 2018). 
In the Eastern Cape Province, high rates of primary transmission have been found with 
approximately 80 % of patients who acquired drug-resistant TB being infected with resistant 
strains from other MDR-TB patients (Klopper et al, 2014). Furthermore, a more recent study 
conducted in Kwazulu-Natal showed that the majority of cases of drug-resistant TB were 
probably due to transmission rather than inadequate treatment of TB (Shah et al, 2017). The 
conclusion drawn from these studies is that transmission of drug resistant strains, rather than 
defaulting drug-susceptible treatment, is fuelling the drug-resistant TB epidemic in South 
Africa. Thus, the focus of intervention needs to shift to prevention of transmission of MDR- 
TB, timeous linkage to the care of those diagnosed with MDR-TB, and treatment with effective 
regimens. This highlights a shift from patient to health care provider factors, and for adequate 
systems and management structures to be in place to ensure adequate management along the 
continuum of care. 
Traditionally, in South Africa all patients with MDR-TB were hospitalised at a centralised 
specialist MDR-TB hospital. However, several challenges have been cited with a centralised 
model of TB care: 
http://etd.uwc.ac.za/
3  
 Inadequate bed capacity: infectious patients remained without treatment whilst 
awaiting admission, potentially causing transmission of drug-resistant TB within the 
community; 
 Patients required to travel far distances to centralised sites affecting retention in care; 
 Institutionalised care fuelling stigma and fear, undermining public health efforts and 
resulting in reduced health-seeking behaviour among presumptive MDR-TB patients 
(Smith, 2010). 
In order to address the challenges associated with a centralised approach to health care, South 
Africa is undergoing health sector reform. Decentralisation of health systems is a pillar of 
health sector reform whereby improved efficiency and quality of services is sought and local 
governance and accountability of the health system is promoted. This ensures greater 
autonomy at lower levels of health services through transfer of authority in planning, 
management, and decision-making from national to sub-national (regional, district or 
municipal) levels (McCollum et al, 2018; Robalino, Picazo, & Voetberg, 2001). 
Regarding the decentralisation of MDR-TB within South Africa, a national policy framework 
was introduced in 2011. This Multi-Drug Resistant Tuberculosis Policy Framework on 
Decentralised and Deinstitutionalised Management (2011) describes relevant national 
legislation protecting TB patient rights, as well as providing an outline for the structure of 
MDR-TB management in South Africa. This policy outlines suggested staffing for both 
centralised and decentralised MDR-TB sites, providing summaries of the roles of individual 
health worker cadres, and an organogram of decentralised treatment. 
The policy stipulates the establishment of decentralised sites to provide an additional level of 
care between centralised specialist DR-TB hospitals and primary healthcare facilities 
(Spotlight, 2014). Furthermore, the policy delineates the functions of a decentralised MDR- 
TB site and can either be at a district or primary health care level responsible for the appropriate 
management of MDR-TB patients within the district where they live. It defines the different 
roles and responsibilities of the management of MDR-TB decentralisation according to various 
levels of care: provincial, district and primary health care level (Multi-Drug Resistant 
Tuberculosis Policy Framework (2011). 
Currently, in the South African context, DR-TB services are decentralised to district level, 
with each district having at least one decentralised site. A decentralised site may be a TB 
hospital with isolation wards for MDR-TB patients or a standalone site within a district 
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4  
hospital or community health centre. The Western Cape is the only province which is 
currently fully decentralised to PHC level (personal communication with National DR-TB 
Director, 2018). 
There is increasing evidence of improved access to care and management through 
decentralisation in South Africa, without compromising treatment outcomes. Loveday et al 
(2018) compared different models of MDR-TB care and found that community-based care was 
more effective in the treatment of MDR-TB than care in a centralised, specialised hospital. Out 
of a total of 1,549 patients, 736 patients were treated at four community-based sites and 813 
patients were treated at the centralised hospital. The authors’ findings showed that MDR-TB 
patients were more likely to have a successful treatment outcome if they were treated at a 
community-based site than centralised hospital (adjusted OR 1.43, P = 0.01) (Loveday et al, 
2018). 
Despite evidence showing improved outcomes with decentralisation (Loveday et al, 2018), the 
implementation of the policy is subjected to certain challenges accompanying the process of 
decentralisation. The challenges of decentralisation of MDR-TB in South Africa have been 
identified to include the establishment of new infrastructure (operational constraints), as well 
as increased training need and demand for supervision (capacity). Furthermore, inter-sectoral 
and community linkages are key (Ndjeka, 2013). However, the process of implementation of 
decentralising MDR-TB and accompanying challenges experienced by the implementers have 
not been investigated. 
 
1.2 Problem Statement 
The Multi-Drug Resistant Tuberculosis Policy Framework outlines the roles and 
responsibilities of the role players but does not consider the capacity of local health systems to 
implement the decentralisation policy. The problem is that the experiences of the 
implementers in fulfilling their roles and responsibilities, specifically in terms of their 
capacity, operational constraints, and linkages between the district and decentralised MDR-
TB site, have not been investigated in the implementation of the MDR-TB Decentralisation 
Policy. It is important to establish the capacity and factors influencing the implementation of 
this policy to ensure that inhibiting challenges are addressed before a national rollout process 
commences. 
The capacity to implement decentralisation of MDR-TB is important in order to improve health 
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outcomes. It is therefore important to investigate the factors influencing implementation of the 
MDR-TB Decentralisation Policy (2011). If these factors are not investigated and addressed, 
optimal rollout of decentralisation leading to improved health outcomes will not be achieved. 
 
1.3 Aim 
The aim of the study is to explore and describe the factors influencing the implementation of 
decentralised MDR-TB services from frontline managers’ perspectives. 
 
1.4 Objectives 
 To compare the actual and ascribed roles and responsibilities of facility-level 
decentralised site management teams (DSMTs) in the implementation of 
decentralised MDR-TB services. 
 To compare the actual and ascribed roles and responsibilities of district level district 
health management teams (DHMTs) in the implementation of decentralised MDR-TB 
services. 
 To identify and describe the operational constraints experienced by DSMTs and 
DHMTs in the implementation of decentralised MDR-TB services. 
 To describe the relationship between the DSMTs and DHMTs in terms of linkages 
between the two tiers of management in implementing decentralisation of MDR-TB. 
 To identify and describe the factors influencing the implementation of decentralised 
MDR-TB services. 
 To provide recommendations to strengthen the implementation of decentralised MDR-
TB services. 
 
1.5 Outline of Thesis 
This thesis will be arranged as follows: 
Chapter 1 introduces the decentralisation policy of drug-resistant TB care and explains the 
rationale behind pursuing this research. Chapter 2 contains the literature review, which will 
focus on the health sector reform, specifically the decentralisation of MDR-TB services. The 
http://etd.uwc.ac.za/
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topics that will be reviewed are the types of decentralisation of health services and the impact 
on implementers of a decentralised health service. Chapter 3 describes the research aims, 
objectives and study design, and provides details about the research methodology of the study. 
Chapter 4 presents the findings of the study. Chapter 5 includes the discussion of the results. 
Lastly, Chapter 6 presents the conclusion of the study and recommendations based on the 
findings of the study about improving the identified challenges and barriers to implementation 
of drug-resistant TB care. 
http://etd.uwc.ac.za/
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2. LITERATURE REVIEW 
 
The literature review will focus on decentralisation of health services in South Africa, 
specifically decentralisation of MDR-TB services. The review will specifically focus on 
the factors influencing the decentralisation of health services; human resource 
management (HRM), lack of resources, inadequate pharmacy services, and lack of 
supportive supervision will be reviewed. In addition, specific literature on the factors 
influencing decentralisation of MDR-TB services will be reviewed: staff shortages, lack 
of knowledge of MDR-TB at primary health care level, drug regimen challenges, Loss to 
Follow Up, stigma as a barrier to treatment access and care, and finally substance abuse 
among MDR-TB patients. 
 
2.1 Decentralisation 
2.1.1 Definitions 
Decentralisation is the “transfer by central (i.e., national) government of specific 
functions, with all of the administrative, political and economic attributes that these 
entail, to local (i.e., municipal) governments which are independent of the central 
government within a legally delimited geographic and functional domain” (Panda & 
Thakur, 2016: 4). It is a term that encompasses a broader, less defined and sometimes 
contradictory group of definitions (Saltman, Bankauskaite & Vrangbæk, 2007). 
Decentralisation is a common feature of reform in both developed and developing 
countries, promoting greater autonomy at lower levels of health services through transfer 
of authority in planning, management, and decision-making from national to sub-national 
(regional, district or municipal) levels (McCollum et al, 2018). Although the process of 
decentralisation varies considerably across different contexts, the ultimate aim of this 
health sector reform is improved efficiency and quality of services through focus on local 
governance and accountability in the health system (Alves, Peralta & Perelman, 2013). 
Administrative decentralisation is defined as the redistribution of authority, 
responsibility, and financial resources for services from national government to local units 
of government agencies, sub-national government or semi-autonomous public authorities 
(World Health Organization, 2018). 
http://etd.uwc.ac.za/
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There are three main types of administrative decentralisation according to the World 
Health Organization (2018) which can be further unpacked as follows: 
De-concentration involves redistribution of decision-making and administration from 
national government to sub-national government, such as to ministry staff working in 
regions, provinces or districts. 
Delegation refers to transfer of responsibility for decision-making and administration 
from national government to semi-autonomous public sector organisations such as 
hospital bodies. 
Devolution refers to sub-national governments having clear geographical boundaries over 
which they exercise authority and within which they perform their functions, utilising 
constitutional law reform to formalise the devolution of powers, roles and accountabilities 
(World Health Organization, 2018). 
In this study, decentralisation of health services refers to de-concentration. However, there are 
different views regarding deconcentration as a type of decentralisation and according to 
Manor, J. (2011), decentralisation designs are often a mixture of the different types of 
decentralisation.  
 
2.2 Decentralisation as an approach to improving efficiency in service 
delivery 
Bossert (1993) has advocated decentralisation as an approach to improve equity, efficiency, 
and quality where the benefits of narrow decision-making bring it closer to the points of 
service delivery. Bossert (1993) further states that decentralisation is a “desirable process for 
improving health systems” and that it has been seen as a key aspect of health reforms.  
Specifically with regard to efficiency of service delivery, there is evidence in the literature to 
suggest that decentralisation has shown improved access to services as well as improved 
treatment outcomes in HIV and TB programmes. 
A study by Boyer et al (2010) assessing the scale up of access to antiretroviral treatment for 
HIV infection in Cameroon showed that decentralisation of healthcare delivery had a positive 
impact on access to ART, with Cameroon reaching one of the highest coverages  in the HIV 
positive and eligible for ART population (58 %) in Sub-Saharan Africa. 
With regard to the impact of decentralisation on the tuberculosis programme, a study 
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conducted in an urban setting in Lilongwe, Malawi (Nyirenda, T. et al, 2003), found that 
decentralisation of TB services that includes the use of directly observed therapy, was 
associated with improved treatment outcomes than that provided by centralised services. 
 
2.2.1  Decentralisation of health services in South Africa 
The National Development Plan of South Africa launched in 2012 is founded on six 
pillars, which focus on eliminating inequality and reducing poverty by 2030. These six 
pillars include the following: 
1. Uniting all South Africans around a common programme to fight poverty and 
inequality and to foster a spirit of unity; 
2. Encouraging citizens to be active in their own development, in strengthening 
democracy, and in holding their government accountable; 
3. Raising economic growth, promoting exports, and making the economy more 
labour absorbing; 
4. Focusing on improving capabilities of both people and the country including 
skills, infrastructure, social security, strong institutions, and partnerships both in 
the country and with key international partners; 
5. Building a capable and developmental state, capable of intervening to correct 
historical inequalities and to create opportunities for more people; 
6. And finally, ensuring strong leadership throughout society who work together to  
solve our problems (National Planning Commission, 2012). 
Quality health care was one of the core elements described in the National Development 
Plan, with two broad ideas underpinning the National Department of Health philosophy: 
firstly, decentralisation of health services through the platform of the district health 
system; and secondly, re-engineering of primary health care (National Planning 
Commission, 2012). 
 
2.2.2 Decentralisation of MDR-TB 
In 2011, the MDR-TB programme recognised the increasing burden of tuberculosis 
fuelled by the HIV epidemic, and specifically the emergence of drug-resistant 
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tuberculosis in South Africa (Multi-Drug Resistant Tuberculosis Policy Framework, 
2011). Furthermore, critical bed shortages for admission of MDR-TB patients were 
identified, and the urgent need to decentralise MDR-TB services was acknowledged. 
Decentralisation of health services was in line not only with the needs of the MDR-TB 
programme, but also with South Africa’s vision of decentralising health services to 
district- level as highlighted by the National Development Plan which has been discussed 
above. 
Therefore, the National MDR-TB decentralisation policy framework (2011) was released 
as guidance for implementation of decentralised MDR-TB care at provincial, district and 
decentralised site levels, including the following key areas: tracing and linkage to care of 
diagnosed MDR-TB patients; initiation of treatment of all MDR-TB cases after 
appropriate assessment, with admission when indicated; provision of Directly Observed 
Therapy (DOT) to all MDR-TB patients attending the unit daily; and ensuring availability 
of drugs as well as monitoring rational usage of second-line drugs. Moreover, 
recommendations are given regarding social support, rehabilitation, educational and skills 
building programmes for patients, provision of education and counselling to all patients 
admitted to hospital, as well as preparation of a discharge plan for all patients, and 
ensuring effective down referrals. 
In terms of monitoring and evaluation, the policy guidelines recommend compiling 
monthly, quarterly, six-monthly, and annual reports of MDR-TB patients started on 
treatment, culture conversion, and treatment outcomes, which should be shared by the 
decentralised sites with the Provincial Department of Health. In addition, regular 
monitoring and evaluation of the MDR-TB programme’s performance is recommended 
in the form of programme reviews that include the district and PHC clinics. 
Monitoring of adverse events is another crucial component of MDR-TB care, to ensure 
that patients are both managed appropriately, and that adverse event reporting is 
conducted. Patients with serious adverse events, as well as those with complicated disease 
or additional resistance patterns including extensively drug-resistant TB (XDR-TB), 
should be referred to the centralised MDR-TB unit (Management of Drug-Resistant 
Policy Guidelines, 2011). 
The concept of decision space was developed by Bossert (1998) in an attempt to measure 
the degree of decentralisation based on the transfer of decision-making (Mohammed et 
al, 2016). According to Roman et al (2017: 373) “the decision space approach attempts 
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to evaluate the effectiveness of different decision space configurations and to provide 
recommendations to design decentralisation processes that will result in better health 
system performance.” Thus, for successful decentralisation to occur, adequate decision 
space is important in ensuring that adequate authority is transferred to district managers, 
which in turn promotes efficiency of services, but also allows ownership and 
accountability of the process at the district level through flexibility to adapt policy to local 
needs of the community (Roman et al, 2017; Peton, 2009). 
However, a case study in Uganda describes the lack of authority over decision-making 
regarding human resource management, highlighting it as a limiting factor in 
decentralisation to district health management teams (DHMTs), and ascertains that 
stronger evidence is needed on decision space and human resource capacities (Alonso- 
Garbayo et al, 2017). The study concluded that it is unclear whether delegating decision- 
making powers from a central to district level results in greater autonomy for DHMTs 
regarding managing their workforce (Alonso-Garbayo et al, 2017). 
Roman et al (2017) states that if decentralisation policies are introduced without clear 
definitions of roles and responsibilities of the various role players, the extent to which 
management decisions can be taken at local level can be challenging. Unclear levels of 
authority can cause conflict and administrative delays (Roman et al, 2017). An example 
of such challenges in South Africa, where when de-concentration from the National 
Department of Health to local departments of health, as well as devolution from national 
to local governments, resulted in health services being accountable to both local and 
national government (Roman et al, 2017). This created confusion over priorities with 
regard to planning and implementation of decentralisation policy (Roman et al, 2017). 
 
2.3 Factors influencing decentralisation of health services 
The following section will review the literature with regard to the key factors influencing 
decentralisation of health services that include: HRM, lack of resources, inadequate 
pharmacy supplies, and lack of supportive supervision. 
 
2.3.1 Health Resource Management (HRM) 
Human Resource Management is one of the key factors identified in the study and 
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includes the following: lack of prioritisation of Human Resources (HR), lack of staff 
complement to provide services, and challenges in implementation of a multi-disciplinary 
team approach. In terms of HR not being prioritised, a study by Dussault and Dubois 
(2003) found that HRM does not receive the same focus as financing and structural 
transformation in many health reforms, resulting in a lack of experiences shared. 
Furthermore, it is necessary to have a staff complement to provide the necessary 
services as found in a study by Kolehmainen-Aitken (2004). This concept is referred to 
by Dubois & Singh (2009) as staff mix, and refers to the number of personnel, mixing of 
disciplines and use of multi- disciplinary teams. 
The importance of human resources management in health care in a global context 
showed that implementation of the multi-disciplinary approach faces significant 
challenges (Kabene et al, 2006). Traditionally, a multi-disciplinary approach focuses 
around specific disciplines, with health care plans being drawn up by medical 
professionals (Kabene et al, 2006). Typically, there is a clinician leading the team who 
determines the care and refers the patient to other health care specialists and auxiliary 
support staff where necessary (Kabene et al, 2006). In this approach, however, there is 
generally little involvement with the patient regarding the care provided. Inter- 
disciplinary health care, on the other hand, is a patient-centred approach in which all 
involved including the patient have input into the treatment planning process (Kabene et 
al, 2006). It was further noted that the aim of this team should not be to have health care 
workers working independently in silos, but rather to focus on the unique skills each 
member brings to the team (Kabene et al, 2006). 
Another factor influencing implementation of policy in the implementation of sexual 
reproductive health (SRH) services thought to be an even greater barrier than staff 
shortages to provision of quality health services was staff morale (McIntyre & Klugman, 
2003). Possible factors affecting the identified staff morale include confusion over 
supervisory responsibility, reduced technical supervision capacity and reduced number of 
supervision visits (Kolehmainen-Aitken, 2004). 
Staff shortages, in addition to lack of staff houses and poor remuneration, are regarded as 
major barriers affecting role players in implementing health reform such as 
decentralisation, creating the link between health reform and staff morale and 
performance in providing quality health care (Mubyazi & Njunwa, 2013). 
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2.3.2. Lack of resources 
A study in China investigating decentralisation of services to people living with 
HIV/AIDS (PLHIV) described lack of relevant medical equipment and laboratory 
services as a barrier to making appropriate diagnoses and providing effective quality care 
for patients (Zhang, 2011). In Uganda (Lutwama et al, 2012) and Tanzania (Frumence et 
al, 2013) the lack of equipment is described as a barrier experienced by health care 
workers in a decentralised health system. In South Africa, implementation of SRH 
services was associated with frustration at being required to implement policies for which 
the necessary resources were available due to delays in budget allocation (McIntyre & 
Klugman, 2003). 
 
2.3.3 Inadequate pharmacy services 
In a Ugandan study by Anokbonggo et al (2004) that assessed the impact of 
decentralisation on health services, including facility utilisation, prescribing and 
availability of essential drugs, the findings showed that despite the perception that a 
decentralised policy led to community empowerment and ownership, it failed to 
improve drug shortages (Anokbonggo et al, 2004). 
In another study by Crowley and Stellenberg that evaluated the adequacy of pharmaceutical 
services for the provision of antiretroviral treatment in primary health care clinics in 
uMgungundlovu district of KwaZulu-Natal (2015), one of the key challenges was that these 
clinics were not equipped to support HIV treatment and care services regarding infrastructure, 
standard operating procedures (SOPs) and trained staff (Crowley and Stellenberg, 2015). 
Lastly, a study that Cameron et al (2012) conducted among primary care nurses in seven 
provinces in South Africa to assess whether nurses in primary care clinics are initiating 
ART after attending NIMART training, showed that only 38 % of participants had 
completed a formal training course in dispensing, and that an understanding of the 
pharmacology of drug interactions in patients with comorbidities is essential for good 
clinical practice (Cameron et al, 2012). 
In summary, inadequate pharmacy services have been identified in the literature as a 
barrier to implementation of decentralised health services.  
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2.3.4 Lack of supportive supervision 
A multi-country study focused on district level management of child health services 
within an Integrated Management of Childhood Illness (IMCI) programme assessed 
whether district teams have the skills, resources, and authority to manage (Doherty et al, 
2018). Insufficient access to supervision of trained child health workers at facilities was 
found to be a key factor affecting decentralisation of health services to a district level. 
Lack of capacity for adequate supportive supervision affected implementation of 
decentralised services (Frumence et al, 2013). The council (district) health department 
was found to have inadequate capacity to carry out supportive supervision at the primary 
health facilities and community level to monitor the quality of health service delivery in 
the whole council (Frumence et al, 2013). The authors reported two main contributing 
factors to this situation: a lack of capacity in terms of transport, and inadequate staff to 
carry out the necessary supervisory visits (Frumence et al, 2013). 
 
2.4 Factors influencing decentralisation of MDR-TB services 
A study exploring whether the treatment journey of a patient with MDR-TB in South 
Africa is patient-centred, found that both patient- and health system-related factors 
resulted in sub-optimal treatment (Loveday et al, 2013). The authors found that health 
systems factors were responsible for most of the barriers encountered during the patient’s 
treatment journey, and included pharmaceutical services, laboratory services, lack of 
adequate monitoring and evaluation systems, poor implementation of treatment 
guidelines, and lack of integration of TB and HIV services (Loveday et al, 2013). 
 
2.4.1 Health system factors 
Staff shortages 
Staff shortages was one of the two major reasons in addition to bed shortages for the 
development of the MDR-TB decentralisation policy; however, progress in addressing 
these issues has been slow and staff shortages remain a significant barrier in 
implementation of the policy (Ndjeka, 2013). 
Staff shortages are a specific barrier in implementation of the TB programme in South 
Africa, where it was indicated that staff shortages result in increased workload, rapid staff 
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turnover, workplace stress and burnout (Dlwati & Mavundla, 2017). Furthermore, 
additional responsibilities in addition to their core responsibility of managing TB patients 
added to their workload under already overburdened conditions (Dlwati & Mavundla, 
2017). 
Lack of knowledge of MDR-TB at Primary Health Care Level 
One of the significant factors identified in the literature in implementing the policy is lack 
of knowledge of MDR-TB specifically at primary health care level. 
An assessment of the knowledge levels of nurses on MDR-TB working at TB units in 
primary health care (PHC) clinics in an Eastern Cape district, showed that less than 40 % 
of PHC nurses had been trained on MDR-TB in comparison to 91 % of respondents who 
had been trained on HIV/ AIDS (Singh & Janse van Rensburg, 2017). Furthermore, 69 % 
of respondents did not have adequate knowledge on how to manage symptomatic contacts 
of MDR-TB while half of the respondents did not have adequate knowledge on how to 
manage asymptomatic contacts of MDR-TB (Singh & Janse van Rensburg, 2017). These 
gaps in knowledge were not only attributed to lack of trainings, but also staff shortages 
resulting in a high turnover of staff within the focal TB clinic at primary health care level 
(Singh & Janse van Rensburg, 2017). 
Drug regimen challenges 
At the time of this study, injection-free regimens with newer agents that are less toxic and 
have improved treatment outcomes were not freely available for uncomplicated MDR-TB 
patients and injections were still part of the WHO-recommended MDR-TB regimen 
unless specific contra-indications such as hearing loss were identified (NDoH, 2017).  
A study conducted in four European countries, namely Austria, Bulgaria, Spain, and the 
United Kingdom, assessed which health care system factors were necessary for optimal 
treatment outcomes in MDR-TB. The following factors were identified: timely diagnosis 
of drug-resistant tuberculosis; measures to ensure access to a full course of treatment and 
support for patients; patient-centred approaches with strong intersectoral collaboration to 
address patients’ emotional and social needs; and motivated healthcare workers with 
sufficient means to support patients (De Vries et al, 2017). One of the specific 
challenges identified was the difficulty in ensuring a full course of treatment for all 
patients with many patients unable to tolerate the injectable agent due to adverse 
reactions; furthermore, lack of evidence-based guidance on optimal drug regimens 
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resulted in clinicians relying rather on professional insight and their own experience; 
and newer agents that are potentially better tolerate with improved outcomes not yet 
being widely available despite WHO recommendation (De Vries et al, 2017). 
 
2.4.2 Patient-related factors 
 
With regard to patient related factors, the following will be discussed: Lost to Follow Up, 
stigma as a barrier to treatment access and care, and substance abuse amongst MDR-TB 
patients. 
Lost to Follow Up 
As a reminder, the term Lost to Follow Up (LTFU) refers to patients for whom there is 
no further information regarding treatment and/or mortality beyond the last known date 
of treatment (Moyo, 2015). 
Churchyard et al (2014) found a generally high LTFU rate among patients being treated 
for MDR-TB in South Africa. A study by Naidoo et al (2017) showed that in terms of 
estimated losses at each step across the TB treatment cascade looking at national registry 
data, laboratory data and published studies 22 % (5,375) of MDR-TB patients did not 
successfully complete treatment (Naidoo et al, 2017). Thus, a significant proportion of 
MDR-TB patients not only fail to be cured but also do not complete treatment. 
In addition, a study by Shah et al (2018) shows that Lost to Follow Up places a burden on 
both the health care system, which reflects poor treatment outcomes, as well as the 
community, where there is potentially ongoing transmission of MDR-TB by infectious 
patients to others. 
Stigma as a barrier to treatment access and care 
Stigma is defined by Goffman as “an attribute that is deeply discrediting which spoils a 
person's social identity or sense of self” (Craig et al, 2016:91). In addition, stigma is an 
important social determinant of health, which can have an impact on both individuals and 
communities regarding TB treatment (Craig et al, 2016). 
The impact of stigma on the TB patient is significant in that it is a barrier to accessing 
health care, resulting in delays in diagnosis and linkage to care, as well as adherence to 
and completion of treatment (Médecins Sans Frontieres, 2018). Stigma is associated with 
poverty, social marginalisation, a risk of transmission and death. Médecins Sans 
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Frontieres (MSF) further states that in South Africa, 34 % of respondents to a national 
stigma survey said they had not shared their TB diagnosis to people outside their home, 
and a similar number reporting being teased, insulted or sworn at because of their TB 
status (Médecins Sans Frontieres, 2018). 
Substance abuse among MDR-TB patients 
Tuberculosis control efforts are often ineffective among patients who abuse substances 
(Deiss et al, 2009; Oeltmann et al, 2009). Evidence suggests that substance abuse has 
driven TB epidemics in a number of countries in the following ways: ineffective TB 
control efforts, poor adherence and poor treatment outcomes, and drug induced liver 
disease caused by TB medication (Jakubowiak et al, 2007; Santha et al, 2002; Suhadev, 
2011; Duraisamy et al, 2014; Saukkonen et al, 2006; Lima & Melo, 2012; Ramappa et al, 
2013). 
In addition, the abuse of alcohol during tuberculosis treatment can result in patients 
discontinuing medication (Jakubowiak et al, 2007; Santha et al, 2002). Furthermore, 
alcohol abuse among tuberculosis patients is associated with not only poor adherence as 
found in the previous studies, but also poor treatment outcomes (Suhadev, 2011). With 
MDR-TB specifically, similar results were found when poor outcomes were discovered 
among patients who consume alcohol (Duraisamy et al, 2014). Several studies have 
demonstrated that alcohol and illicit substances potentially aggravate anti-tuberculosis 
drug induced liver disease (Saukkonen et al, 2006; Lima & Melo, 2012; Ramappa et al, 
2013). 
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3. METHODOLOGY 
 
This section describes the methodology used for the study, and outlines the following: the 
study design, research setting, and study population. It continues with the sampling 
procedure, data collection, data analysis, rigour, and finally ethical considerations. 
 
3.1 Study Design 
A qualitative inquiry was conducted since it is a method that allows for a flexible 
approach, and for situations to be described from the perspectives of those involved 
(Robson, 2011). It is therefore specifically suited to the “bottom-up” perspective in this 
study. Furthermore, a qualitative approach was suitable to explore, in-depth, the 
experiences of the managers in the implementation of the multidrug-resistant 
tuberculosis (MDR-TB) decentralisation policy. It has been selected because it is 
suitable in situations when the main research questions are “how” or “why” (Yin, 2013); 
in this case not only to ascertain the different factors that influence decentralisation but 
to more fully understand the context and to gain the richness of data required by this 
study design, how these factors affect implementation will be explored. 
 
3.2 Research Setting 
This study was conducted in the Eastern Cape Province, South Africa. The Eastern Cape 
is the second largest province in South Africa located on the east coast and is nestled 
between the Western Cape and Kwa-Zulu Natal. It has a surface area of 168,966 km² and 
has the third-largest population of 6,996,976 (Municipalities of South Africa, 2018). The 
Province is divided into two metropolitan municipalities (Buffalo City Metropolitan 
Municipality and Nelson Mandela Bay Metropolitan Municipality) and six district 
municipalities, which are further subdivided into thirty-one sub-districts (Municipalities 
of South Africa, 2018). 
 
3.3 Study population 
The study population includes all managers directly involved in decentralisation of MDR- 
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TB. There are two tiers of managers: the first tier located on the periphery, for the 
purposes of this study referred to as the decentralised site management team (DSMT) 
situated at the decentralised site, and the second tier at the district level, the district health 
management team (DHMT) which is based at the district office. All the managers that 
comprise the study population are directly involved in managerial activities as defined by 
the MDR-TB decentralisation policy (2011). The policy described four different 
categories of managers and they were included since these categories are responsible for 
all managerial activities at decentralised sites. There is only one manager in each category 
of managers and in each decentralised site. 
Table 1 below describes the job titles and main roles of each category. 
 
Table 1: Categories of Managers within the Decentralised Site Management Team (DSMT) 
and District Health Management Team (DHMT) 
Management 
Team 
Management 
Category 
Main Role 
DSMT Chief 
Executive 
Officer 
(CEO) 
Provides supervisory role of management 
team responsible for financial, human 
resources and physical resources. 
Clinical 
Manager 
Provides oversight of clinical staff in the 
clinical management of patient. 
Nursing 
Services 
Manager 
Coordinates outpatient services, liaising 
with a district TB coordinator and PHC 
clinics. 
Focal DR-TB 
Nurse 
Coordinates clinical care of in-patients 
with other health care professionals. 
DHMT District TB 
Coordinator 
Coordinates all activities within the 
district, including tracing and linkage to 
care, availability of drugs, and continuum 
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of care post discharge. 
(Source: Adapted from Management of Drug-Resistant Tuberculosis Policy Guidelines, 
2013). 
 
3.4 Sampling Procedure 
 Convenience sampling was conducted in this study and was done in three stages. 
Stage 1: Selection of province 
Firstly, the Eastern Cape Province was selected since it is one of the high-burden provinces of 
TB in South Africa (Statistics South Africa, 2016). TB was noted as the leading cause of 
death in the province with 5,210 (7.9 %) reported deaths in 2016 (Statistics South Africa, 
2016). Furthermore, the Eastern Cape Province has supported a decentralised approach to 
MDR-TB since initial rollout of the national MDR-TB decentralisation policy in the province 
in 2011, with decentralised services available in all eight districts and in twenty-eight sub- 
districts. The provincial coverage of DR-TB services in 2017 was at 97 % (personal 
communication with Eastern Cape Provincial DR-TB Manager, 2017). Furthermore, this 
province was selected since the researcher has been extensively involved in both clinical and 
programmatic support in the Eastern Cape, allowing a good knowledge base of the TB 
programme within the province in line with case study research. 
Stage 2: Selection of districts 
The second stage involved selection of the districts. The districts were selected according 
to the sites the researcher negotiated access to and where the researcher was working at 
the time, thus the districts selected are based on which district the negotiated sites fall 
under. In total, three districts were selected. 
Stage 3: Decentralised site selection 
Decentralised site selection was based on the sites the researcher is familiar with and has 
negotiated access with management. In total, four decentralised sites were selected. 
Three of the four sites are TB hospitals with MDR-TB services at the hospital, and one 
site is a district hospital with decentralised MDR-TB services integrated into the general 
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services provided. With regard to infrastructure and staffing including reporting lines, 
the structures were the same in each site. 
Stage 4: Selection of participants 
Since there is only one manager at each position (CEO, Clinical Manager, Nursing 
Services Manager and Focal DR-TB Nurse) in each of the four sites, once the sampling 
for the province, districts and sites was complete there was no need to sample the 
participants. In total, in the peripheral tier of management at the decentralised MDR-TB 
sites (DSMT), there were sixteen participants, and in the district tier of management 
(DHMT), there were two participants for this study, thus a total of eighteen participants 
were interviewed. 
In summary, the research study was conducted in three districts, from which four 
decentralised MDR-TB sites were sampled. A total of eighteen participants were 
included with four participants in each site and two participants from the district. 
 
3.5 Data Collection 
Data collection took place during the period from December 2017 to May 2018. Semi- 
structured interviews were used, allowing the participants the freedom to express more 
fully a deeper understanding of the unique roles and responsibilities, as well as the 
challenges faced in implementing these activities (Appendices 1-5). 
The researcher arranged a face-to-face interview with each participant at a time and venue 
of their convenience to ensure privacy that the participant felt comfortable with. All 
interviews except for one were conducted either in the manager’s office or the boardroom 
at the site. One interview with the Focal DR-TB Nurse was conducted in an out-patient 
clinic. The interviews were conducted in English, since all the participants are fluent in 
English and it is the language used in their management roles. All interviews were 
recorded using a Voice Recorder App on a smart phone, since this was the technique that 
the researcher was most familiar with and were uploaded onto her personal computer and 
transcribed verbatim. The first two interviews were transcribed by the researcher so that 
she could gain familiarity with the material and the process, after which a professional 
transcription company was used for transcribing the remainder of the interviews. 
A debriefing session was used after each interview whereby the researcher asked the 
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participant to share how he/she experienced the interview and whether they were satisfied 
with the process. In addition, member checking, also known as participant or respondent 
validation, was used as a technique for exploring the credibility of results (Robson, 2011). 
This was done at the end of each interview, where the researcher summarised the 
information and then questioned the participant to determine whether the participant was 
satisfied that what was recorded was a true reflection of what the participant was saying. 
Furthermore, the researcher shared the transcripts with participants to check that they 
agreed that the transcripts truly reflected the content of the interview. This process, known 
as interviewee transcript review, is a technique for improving the rigour of interview- 
based, qualitative research and involves providing interviewees with verbatim transcripts 
of their interviews in order to verify accuracy, correct errors, and provide clarification if 
necessary (Hagens, Dobrow & Chafe, 2009). 
 
3.6 Data Analysis 
Thematic analysis using a framework method was used since it provides a highly 
systematic method of categorisation and organisation (Gale, 2013). It was deemed 
appropriate because semi-structured interview guides have been developed based on and 
aligned to the decentralisation policy of MDR-TB health services, creating a 
predetermined set of themes. The framework was used to develop descriptive and 
explanatory conclusions clustered around the predetermined themes (Gale, 2013). 
A thematic coding approach as proposed by Robson (2011) was used in the following 
steps: 
 Familiarising yourself with data; 
 Generating initial codes; 
 Identifying themes; 
 Constructing thematic networks; 
 Integration and interpretation (Robson, 2011). 
Familiarising yourself with study data 
The researcher transcribed the first two interviews herself to gain familiarity with both 
the process and the content. Due to time constraints a professional transcription service 
was used for the remaining sixteen interviews. The researcher read through each 
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transcription several times to familiarise herself with the data. 
Generating initial codes 
Initial codes were jotted down on paper while reading through the transcripts, bearing in 
mind the objectives of the study and looking for codes that described factors influencing 
implementation of the MDR-TB decentralisation policy. The researcher then uploaded 
the transcripts onto Atlas.ti to use its auto-coding function and applied these codes across 
the entire data set whereby similar extracts identified were given the same code. In total, 
twenty-five codes were used. For ease of reference, document groups were used for each 
of the five role players, namely: CEO, Clinical Manager, Nursing Services Manager, 
Focal DR-TB Nurse and District TB Coordinator. 
Identifying themes 
Once the codes had been identified, the researcher collated them into themes using code 
groups in Atlas.ti under the following: 
 Capacity 
 Data issues 
 Infection control issues 
 Linkages/referrals 
 Lost to Follow Up 
 PHC clinic issues 
 Resources 
 Rural challenges 
 Social issues 
 Staffing issues 
Constructing thematic networks 
A thematic map of the analysis was then developed by the researcher, which was done 
manually whereby the researcher went through each coded section in the Atlas.ti 
documents and identified those quotations deemed relevant to the theme. An example of 
the thematic analysis is provided in Appendix 7. The initial themes were reviewed, and 
those themes identified above fitted into one network. A significant number of the themes 
http://etd.uwc.ac.za/
24  
changed as the findings were written up. For example, an initial theme of ‘capacity’ was 
deemed too broad and was redefined as ‘training’, in line with the idea that thematic 
network analysis is a reflective, ongoing process that develops over time and involves 
going back and forth between phases as proposed by Nowell et al (2017) and Braun & 
Clarke (2006). During this process, no overlapping of codes or themes was identified 
therefore no themes were deleted, however one new theme was identified (roles and 
responsibilities). 
Integrating and interpretation 
Using the network developed above, the researcher was able to further refine the themes 
through a process of exploring, describing, and interpreting patterns as described by 
Robson (2011). The researcher’s supervisor was key in assisting during this step, whereby 
specific themes were finalised during drafting of the findings. 
 
3.7 Rigour 
The following strategies were used to ensure rigour in this study: providing a thick 
description, developing an audit trail, ensuring dependability and confirmability through 
member checking, reflexivity, and peer debriefing. 
In this study the researcher has provided sufficient thick description of the context in 
which the work was undertaken to allow readers to have a proper understanding of it, 
thereby enabling them to compare the instances of the phenomenon described in the 
research report with those that they have seen emerge in their situations, a strategy 
proposed by Shenton (2004). 
Audiotapes were used for recording the discussion and ensure that there was a clear audit 
trail from raw data to final themes (Gale, 2013). In addition, written notes were made by 
the researcher directly onto the interview guide during the interviews, to record points 
that stood out as important with each question and were stored in a folder which was only 
accessible to the researcher. Interviews in audio format using Mp3 files, in addition to 
reflection notes that were captured at various times throughout the research process were 
stored on the researcher’s personal laptop. 
Transferability has been ensured by the researcher using thick description, to enable other 
researchers to assess whether the findings are transferable to their own setting (Korstjens 
& Moser, 2018). The researcher has also taken into consideration dependability and 
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confirmability by recording not only the findings, but also the processes, to allow the 
work to be repeated if not necessarily to gain the same results (Shenton, 2004). 
Reflexivity was a further strategy whereby the researcher kept reflection notes throughout 
the study to allow capturing of thoughts, feelings and ideas to reflect upon once data was 
analysed, and which were then added to the discussion of the study findings. Reflexivity 
is the process of continuous reflection on the research, examining both oneself as 
researcher, and the research relationship, as advocated by Alley, Jackson & Shakya 
(2015). 
Peer debriefing is the review of the research process by someone familiar with the 
research or the topic being studied and gives the researcher a sounding board to challenge 
and question methodology and provide feedback and support (Lincoln & Guba (1985). In 
this study, peer debriefing after each set of interviews was provided by the researcher’s 
supervisor through telephonic communication and review of written reflections shared by 
the researcher. Raw data in the form of audio tapes were also shared with the researcher’s 
supervisor which allowed the supervisor to assess the interview technique used and to 
provide support on how to improve interview techniques to ensure richness of data. 
Furthermore, member checking, described above, was used as a technique for exploring 
the credibility of results (Robson, 2011). Both peer debriefing and member checking are 
forms of validity in qualitative research. 
 
3.8 Ethical Considerations 
The study proposal was submitted to the Faculty of Community Health and Health 
Sciences, the Higher Degrees Committee of the University of the Western Cape, and the 
University of the Western Cape’s Ethics Committee for approval. Once ethical clearance 
was obtained from the University of the Western Cape, permission to conduct the study 
was obtained from the Eastern Cape Epidemiology, Surveillance and Research 
Directorate. Permission was also sought from the Decentralised Site Management Teams 
(DSMTs) and the District Health Management Teams (DHMTs) for the participants 
functioning at both the decentralised sites and district level. 
Prior to the interview process, participants were verbally invited to participate in the study 
and the details of the study were explained to them. They were provided with a Participant 
Information Sheet with details of the purpose of the study and data collection methods to 
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be used in the study, assurance of confidentiality, and their right to refuse participation. 
Willing participants were informed that should they feel uncomfortable at any stage 
during the interview, they were not obliged to answer the question. It was explained to 
them that should they experience any psychological or other discomfort, they would be 
referred to a health care provider in a confidential manner. Furthermore, participants were 
made aware that they could withdraw at any time during the research study without any 
negative consequences to themselves. They were then requested to provide written 
consent to voluntarily participate in the study, as well as for their interview to be audio- 
recorded and their data to be used in a publication of findings. The Informed Consent 
Form and Participant Information Sheet were in English since, as managers in the 
Department of Health, they were assumed to be proficient in English. 
Due to the participants working in different districts, face-to-face interviews were 
arranged at a time and place of convenience of each participant. The interviews were 
audio-recorded with the permission of the participant and transcribed verbatim. Each 
respondent was given a unique identifier to replace their names to maintain anonymity. 
The paper-based notes were stored in a locked cupboard, while the electronic version of 
the recordings and transcripts were stored using password-protected files on a password- 
protected computer to which only the researcher had access. Where individual statements 
from the interviews potentially revealed the identity of a participant, the information was 
not used in the written findings. The audio recordings and transcripts will be destroyed 
after a five-year period of time has lapsed. 
To mitigate the fear of exposure, the researcher established a good rapport with the 
participants, in most cases adding to an existing level of trust due to the working 
relationship between the researcher and participants. The results and recommendations 
will be disseminated with the sites, districts, and the province on an appropriate platform 
as agreed between the researcher and participants to ensure that feedback is given to those 
who participated in the study and to inform quality improvement. 
In summary, this chapter describes the qualitative design and case study approach used in 
the study. Data collection techniques, as well as the different phases utilised during data 
analysis, have been described. Finally, an explanation of the rigorous process and ethical 
considerations that were considered during the study were described. 
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4. FINDINGS 
 
This chapter presents the findings on the roles and responsibilities of the different role 
players and the factors influencing the implementation of the multidrug-resistant 
tuberculosis (MDR-TB) decentralisation policy (2011). 
The findings of the study can be classified into two main categories; roles and 
responsibilities of key role players at decentralised MDR-TB sites, and factors influencing 
implementation of the MDR-TB decentralisation policy. Findings under roles and 
responsibilities will be divided into ascribed role, actual role, and comparison between 
the two. Findings included under factors influencing implementation of MDR-TB policy 
will include the following: operational constraints (patient flow along continuum of care, 
ambulatory care, and additional responsibilities), health system factors (poor alignment 
of NGOs to government services, lack of integration of TB and HIV, and lack of 
communication between different levels of care), health-care provider factors (staff 
shortages, staff morale, and fears of contracting TB), and lastly patient-related factors 
(Lost to Follow Up, stigma and social grants for MDR-TB patients). 
It is important to note that the factors that are teething issues due to the recent 
implementation of the policy will be differentiated from the more fundamental health care 
system factors. 
 
4.1 Roles and responsibilities of key role players at decentralised MDR-TB 
sites 
As a reminder, the key role players in this research are the Chief Executive Officer (CEO), 
Clinical Manager (Doctor), Nursing Services Manager (NSM) and Focal DR-TB Nurse 
(FN). 
 
4.1.1 Ascribed role 
A list of ascribed responsibilities has been extracted from the policy and is shown in Table 2 
below. 
 
http://etd.uwc.ac.za/
28  
Table 2: Ascribed responsibilities of each role player at decentralised site management level 
Role 
player 
Responsibilities 
Chief 
Executive 
Officer 
 Develop appropriate strategic and operational plans and 
budgets. 
 Provide oversight of the highest quality clinical and non- 
clinical services. 
 Ensure regular collection, evaluation and reporting of 
high-quality data on services provided. 
 Liaise with cluster managers, hospital boards and 
community groups as well as other district hospitals. 
Clinical 
Manager 
(Doctor) 
 Assess patient for co-morbidities and request baseline 
tests. 
 Initiate DR-TB treatment, monitor patient clinically, and 
adjust treatment where necessary. 
 Report adverse drug reactions to Medicines Control 
Council. 
 Provide prompt referral for tertiary or specialist care 
where necessary. 
 Ensure regular clinical monitoring through timeous 
laboratory testing. 
 Educate nurses and other members of team. 
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Nursing 
Services 
Manager 
 Liaise with mobile teams and staff at facilities 
administering DR-TB treatment. 
 Ensure that recording and reporting procedures are up to 
date. 
 Liaise with other stakeholders in the geographical area. 
 Organise and document six-monthly contact screening. 
 Trace newly-diagnosed DR-TB patients and facilitate 
linkage to care and admission if necessary. 
 Arrange regular monthly visits for outpatients. 
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  Coordinate and monitor tracing team activities. 
Focal DR- 
TB nurse 
 Monitor inpatients and refer to doctor where necessary. 
 Coordinate household assessment, discharge and linkage 
to outpatient services. 
 Manage weekly outpatient clinic. 
 Provide Voluntary Testing and Counselling (VCT) for 
HIV. 
 Provide educational talks to patients. 
 Ensure that the paper-based MDR-TB register is updated 
regularly. 
 Ensure patients who miss appointments are traced. 
 Liaise with mobile teams regarding patient management. 
(Source: Adapted from Management of Drug-Resistant Tuberculosis Policy Guidelines, 
2013) 
 
4.1.2 Actual role 
The following list of activities was extracted and summarised, reflecting the actual roles 
and responsibilities as expressed by participants: 
Chief Executive Officer (CEO) 
    Resource management (including human resource, material and financial) for 
implementation of those policies, not only the decentralisation policy but also 
infection control and national core standards policies; 
 Oversight of the various multi-disciplinary team committees within the site; 
 Reporting of monthly expenditure to the Budget Advisory Committee Meeting; 
 Management stakeholder communication including district/provincial and 
public engagement through the hospital board; 
 Provision of oversight of linkage within district and outreach programmes to 
ensure integration of service delivery at primary health care level. 
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Findings showed that where the CEO was a doctor, due to the additional expertise the 
responsibilities of the CEO included purely clinical activities: “60/40 doing administrative 
work and then the other 40 % it’s more clinical, seeing patients… I have one Medical 
Officer… when he’s not around then I would have to be a full-time doctor including after-
hours care and OPD [Out Patient Department] cases” P13 (1:171). 
Clinical Manager 
 Oversight and coordination of the clinical component of staff, including 
doctors, pharmacists, social workers, radiographers, occupational therapists, 
and audiologists; 
 Ensuring quality of clinical care through adherence to guidelines regarding 
treatment regimens, regular monitoring (laboratory), and side effect 
management; 
 Oversight of pharmacovigilance; 
 Management of clinical services budget; 
 Non-clinical responsibilities include the role within various committees, 
including skills development, complaints, and accommodation committees. 
A responsibility specific to a rural clinical manager when questioned about 
implementation of responsibilities in line with the policy, was that of providing a holistic 
approach to integrated care in a specialist vertical programme: “it’s the constant battle 
between vertical and horizontal programs. You know the reason there’re vertical 
programs is [sic] because it is more efficient and easier to remember to do the same thing 
ten times in a row and you use the same paperwork” P6 (18:29). The same role player 
further explained that one of his responsibilities is to ensure clinical staff has a balance 
between focal and other staff in the decentralised site: “allowing somebody to champion 
that without deskilling the rest of the team so that that’s always and finding balance” P6 
(18:30). 
Nursing Services Manager 
One of the nursing services manager described how she implements her responsibilities 
in line with the policy as follows: “I’m like an eagle, I’m an umbrella that is covering all 
the stakeholders to ensure that things are happening until the patient has been awarded 
an outcome that will mean at the end of the treatment term and then the nursing side… 
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the bedside nursing, ensuring that policies and prescripts are available, and they are 
known, they are applied with understanding. Where I pick up difficulties or any problems, 
then on-site training even if it’s just information sharing, then further than that we extend 
to institutional training, further than that we go to the sub-district training” P3 (11:90). 
Extracts from other Nursing Services Manager interviews in terms of actual activities 
performed are included in the list below: 
 Providing a supervisory role from diagnosis, admission, monitoring of the patient 
and show that the correct treatment is given according to the regimen and that 
regular monitoring is performed; 
 Ensuring monthly follow-up of patients; 
 Ensuring that those patients on injectable phase of treatment have the necessary 
audiometry testing to exclude drug-induced hearing loss; 
 Supervision of nursing staff in monitoring of all adverse events and ensuring 
adequate intervention through communication with the clinicians as well as the 
multi-disciplinary team including audiology and social worker; 
 Facilitating stakeholder engagement, including non-governmental organisation 
(NGO) support, for patients to receive the necessary support in completing 
treatment once discharged into the community. 
Focal DR-TB Nurse 
Extracts from interviews with Focal DR-TB Nurses in terms of actual activities performed 
are included in the list below: 
 Providing support as outreach nurse and doing reviews at the clinics in the 
catchment area for that specific decentralised site; 
 Providing mentoring on DR-TB management for primary health care nurses; 
 Liaising with the pharmacists and ensuring that the patient understands the 
medication and side effects, and that side effects are managed and reported; 
 Participating in home visits to the newly diagnosed TB patients’ homes to assess 
social issues and infection control, and establishing a support system for 
discharge; 
 Doing home visits to patients who are interrupting treatment and provide 
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counselling; 
 To educate and screen family members;  
 To provide the linkage for clinical support of the HIV programme; 
 To ensure timeous updating of records of both the patient folders and the registers. 
 
4.1.3 Comparison between actual and ascribed role 
In general, there is a similarity between the actual and ascribed roles of the role players. 
As highlighted in Appendix 6, actual responsibilities that are not included under ascribed 
roles include the following: with regard to the CEO, findings suggest that in addition to 
the actual role of ensuring implementation of the decentralisation policy, there are other 
policies including infection control and national core standards policies that are not 
mentioned in the ascribed role; furthermore, the actual role of the Clinical Manager 
includes management of the clinical budget, as well as participation in non-clinical 
committees including skills development, complaints and accommodation committees 
over and above the ascribed roles included in oversight of clinical function; with regard 
to the Nursing Services Manager, the actual role includes ensuring those patients on 
injectable agents have the necessary audiometry testing to exclude drug-induced hearing 
loss; and finally, with regard to the role of the DR-TB focal nurse, one of the key roles 
mentioned that does not fall under the ascribed role, is that of mentoring on DR-TB 
management for primary health care nurses. This additional activity, as previously 
discussed, should fall under the responsibility of the district and not the decentralised 
MDR-TB site. 
 
4.1.4 Additional responsibilities 
One of the identified factors regarding roles and responsibilities was the expectation to 
take on additional responsibilities over and above the responsibilities of that particular 
role player: “You know nobody has a scope yes we’ve got a kind of a usual job 
description” P6* (18:27). Furthermore, role players are required to cover where specific 
positions are not filled: “There is no Nursing Services Manager on the organogram for 
the hospital. There is also no Area Manager. So the Operational Manager is performing 
the duties of Nursing Services Manager and Area Manager. And I have to cover in the 
wards when I’m needed. I also have to do outreach because there is only one sister for 
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outreach” P15 (18:106). 
Findings showed that some doctors at decentralised sites are expected to perform duties 
outside of the decentralised site: “There’s a huge shortage of doctors, which is another thing, 
so much that we end up having…to work in the district hospitals” P2 (13:101). 
The findings suggest that the hospitals are required to take on the role of training and 
mentoring PHC sisters due to an apparent lack of knowledge amongst the clinic 
supervisors: “I don’t even think the clinic supervisors has either the knowledge to support 
them [PHC Nurse] because if the sisters knew that their supervisor is having the capacity, 
they would rather phone them, but they don’t. They phone us” P16 (5:99). This appears 
to impact on the management and quality of care of DR-TB patients at PHC (district) 
level: “There's poor, or there's mismanagement of patients. Because, I believe that we 
need to look at our indicators and how we perform but also at the quality of care, this is 
important to me as a primary healthcare clinician. And, both I'm going to say, both is 
lacking” P18 (16:27). 
In terms of capacity, according to the findings, PHC staff view DR-TB as an additional 
burden that should be managed at the decentralised sites: “You know nurses really need 
to have… Their mind need to change and I think this is what makes it difficult when I say 
that they don’t embrace DR-TB, because to them it's an extra burden that is now being 
given to them, and they feel that we don’t cope with the burden of susceptible TB, and yet 
you bring this onto us” P18 (16:28). 
Furthermore, findings amongst clinicians interviewed suggest lack of capacity at PHC- 
level where PHC nurses should not be expected to manage complex DR-TB cases: “You 
know the next stage of decentralisation going to primary healthcare I think the expertise 
is a challenge. There’s a tendency sometimes in primary care that we just add another 
thing to the PNs [Professional Nurse] plate and the reality is that we’re asking a lot of 
our primary health care nurses already… and then to add in like DR-TB it’s not quite as 
simple as it looks” P6 (18:23). 
Therefore findings show that the requirement to assume additional responsibilities is an 
issue in both the decentralised site and other facilities including PHC clinics. 
 
 
*P is used to anonymously link the participant from each interview to each specific role 
and MDR-TB site.  
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4.2 Factors influencing implementation of MDR-TB decentralisation policy 
4.2.1 Service delivery factors 
The following service delivery factors will be discussed: patient flow on the continuum 
of care, daily injections and ambulatory care, and additional responsibilities. 
Patient flow on continuum of care 
All activities conducted are interwoven into one multi-disciplinary approach which can 
be visualised according to patient flow across the continuum of care from the diagnosis 
of a patient to the successful outcome of the patient, namely cure (culture conversion) or 
completion of treatment. 
Firstly, any patient who tested positively on symptomatic screening for TB at a health 
care facility requires a diagnostic test. If the patient is able to cough, this is in the form of 
a sputum GeneXpert test which is sent to the laboratory to determine whether there is 
confirmation that the patient has active TB and if so, whether there is rifampicin resistance 
(RR). All RR-TB patients, whether rifampicin mono-resistant or confirmed multi-drug 
resistant, are treated with an MDR-TB regimen and need to be traced, counselled, and up- 
referred from the PHC level to the nearest decentralised site for initiation of treatment. In 
the Eastern Cape Province only certain TB facilities (decentralised MDR-TB sites) have 
been selected as having capacity for initiating MDR-TB treatment. 
Once the patient has reached the decentralised site, a multi-disciplinary team approach 
ensures the following: that appropriate assessment is conducted including taking the 
necessary baseline laboratory tests and a management plan is prepared (doctor/ nurse); 
that the patient and family are counselled and any social issues are addressed (social 
worker); and that recording is done in the patient treatment card, the paper-based register, 
and the electronic register (EDRWeb). The patient is either hospitalised or initiated on 
treatment as an outpatient (ambulatory care), depending on various factors including how 
ill the patient is, infectiousness of the patient, level of resistance, and social support in the 
home and community. 
If the patient is discharged from the decentralised MDR-TB site to the clinic, there needs 
to be adequate communication between the two levels of care regarding transport, the 
patient management plan and dates of monthly reviews at the decentralised site. 
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Figure 1 below illustrates the activities at the decentralised site level and other levels of 
care as visualised according to this patient flow: 
 
 
Primary Health-Care Facilities/General Hospitals 
• Screen all attendees for TB 
• Collect a sputum 
• Send the sputum specimen to laboratory for testing 
 On receipt of results confirming 
RR-TB/DR-TB: 
• Trace patient 
• Counsel patient and explain the 
management and when 
indicated, the need for 
hospitalisation 
• Conduct contacts tracing and 
testing if necessary 
 Laboratory  
 • Diagnosis 
• Report sent to requesting facility and DR- 
TB site within 24 hours of confirmation of 
diagnosis 
 
 
 
 
 
Diagnosed patient referred depending on severity of disease & proximity to hospital and 
initiation of treatment 
Decentralised DR-TB Unit 
Patients are either hospitalised or initiated on treatment as outpatients. Before initiating treatment: 
• Conduct an appropriate assessment; secure written consent; counsel the patient and family; 
prepare a management plan with the patient’s consent; complete DR-TB treatment card; and 
register in DR-TB register. 
 
 
Patients to start in ambulatory care Patients admitted until 
TWO negative TB smear 
microscopy 
Patients admitted 
until AT Least 
ONE negative TB 
culture (3-6 
months) 
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• Patient is ambulant, in fair to good 
general condition (BMI 
> 18.5) 
• Patient is low grade transmission 
risk (smear negative) 
• Patient is smear microscopy 
positive but is stable 
• All GeneXpert positive with 
resistance to rifampicin started on 
MDR-TB treatment 
• Very sick MDR-TB 
patient 
• Patient with very high- 
grade transmission risk 
(three plus smear 
positive) 
• Patients who do not 
have an extensive 
resistance pattern 
• Pre-XDR-TB 
• XDR-TB 
patient 
• MDR-TB re- 
treatments 
Figure 1. Patient flow on the continuum of care. 
(Source: Adapted from Management of Drug-Resistant Tuberculosis Policy Guidelines, 
2013). 
Daily injections and ambulatory care 
According to the MDR-TB Decentralisation Policy, stable patients who are not deemed 
highly infectious to others (smear negative patients) and have adequate household support 
may be treated as ambulatory and do not require admission (2011:15). However, 
ambulatory care still requires six-day-per-week injections which is not feasible from an 
operational perspective: “the researchers really should try and work out what’s practical 
before they trial six-day-a-week injections. So, we do five-day-a-week injections because 
that team isn’t functional at the moment” P6 (18:31). 
It was evident from the findings that PHC clinic services are limited to during the week 
only: “Since our primary healthcare facilities is not open, they are closed over weekends” 
P18 (16:34). As a result, findings suggest that patients are being admitted in order to 
ensure that they receive six-day-per-week injections rather than because they are ill: “The 
patient needs six days of kanamycin, so if there’s somebody out there, we only had one 
patient who’ve been treated outside because a sister in the community was willing to give 
the Saturday’s dose, but otherwise we admit all the patients” P16 (5:110). This results in 
further bed shortages, whereby sick patients who require admission are referred to 
neighbouring sites. 
When probed further, it was felt that even if there were available injection teams, the 
logistics of getting them to these remote clinics especially on weekends, “…will be a 
challenge. I mean resources, I cannot see” P16 (5:113). Transport was mentioned as a 
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specific factor for the outreach teams, “Our outreach team used to go and try to use the 
cars of the hospital but it’s not adequate for the terrain. If the patient is like maybe in 
town, it’s fine, but most of our patients stay in settlement camps, so it’s not conducive” 
P12 (6:133). Difficulty locating patients was another issue affecting outreach teams: 
“there’s a whole lot of new areas that are coming up here in our area. So there’s no clear 
street names, there’s no street numbers. So it’s difficult also to locate a patient” CM3 
(3:77). 
Therefore, implementation of six times weekly injections as advocated by updated 
national policy recommendations and informed by the Bangladesh study when this study 
was conducted (Sotgiu, 2017), are limited by operational constraints in our research 
setting. 
 
 
4.2.2 Health system factors 
 
Health system factors include the following: poor alignment of NGOs to governmental 
services, lack of integration of TB and HIV services, and lack of communication between 
different levels of care. 
Poor alignment of NGOs to governmental services 
NGO-funded activities do not appear to be aligned with the department of health’s 
outreach services: “So, that's the kind of challenges that we have now, and therefore, we 
have tried it, but it's difficult really because we tried to align the NGOs with our, ward- 
based outreach teams, you know, but, it's difficult” P18 (16:30). 
A specific example identified from the findings was the issue of linkage to care, that is 
referring diagnosed patients to an appropriate level of care for treatment, “…at the 
moment, we have to be honest that not all patients that has been diagnosed has been 
linked to care…you have this NGO that is funded for, I'm just making an example, for 
HCT [HIV Counselling and Testing], and it's not funded for linkage to care” P18 (16:35). 
This lack of alignment of NGOs to governmental services affects the role players’ efforts 
in ensuring adequate outreach services in order to effectively carry out their 
responsibilities across the continuum of care. 
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Lack of integration of TB and HIV services 
In addition to lack of alignment between NGOs and governmental services, there does not 
appear to be integration of TB and HIV services: “And what they also mentioned was, 
they are separately employed for TB and someone separate for HIV. And the ones that 
are working for TB, they are all moving towards the HIV side because they are being paid 
the stipend is a little bit more. So there is no integration from their side as well. So if I go 
to your house, even if anybody is coughing, it’s none of my business because I’m here to 
test for HIV” P15 (15:109). Integration of services at community-based level in order to 
ensure that patients receive the full package of care as required by the DR-TB programme 
is therefore an area which is lacking according to the findings. 
Furthermore, lack of retention in care of patients on antiretroviral therapy impacts on the 
burden of TB: “HIV positive patients on ART, they default like crazy…because the patient has 
now defaulted ART, the patient becomes now sick, and we know the first opportunistic infection 
is TB, which means then, it adds to our caseload” P18 (16:36). 
In addition, it appears that the district takes ownership of HIV training but training on TB 
is primarily the responsibility of the decentralised sites: “At the district level they also 
have those training there’s never anything that deals with TB…there’s a lot though 
around HIV, but TB and MDR, I think the district wants it to be like the TB institutions 
have to be coordinating their own TB, you know, information” P9 (2:102). 
Lack of communication and coordination between different levels of care 
Lastly, communication and coordination of services between the decentralised sites, 
district, PHC clinics, and ward- based outreach teams is required, an area which was 
highlighted as a gap. Lack of communication refers to two distinct areas, firstly lack of 
communication between staff at the different levels of care; and secondly, lack of 
communication of data between the different levels of care. 
Where staff is concerned, the following finding was evident: “They are not 
communicating properly with the clinics, so there is a gap between the districts and the 
clinics” P11 (4:199). Lack of communication was also a factor influencing activities of 
ward-based outreach teams supporting the PHC clinics: “When it comes to ward-based 
outreach teams…there isn’t that kind of integration... I don’t even think there’s 
communication” P9 (2:101). This affects linkages between the decentralised site and the 
district, a key responsibility of role players interviewed. 
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Doctor 
Data Capturer Nurse 
Clinical 
Psychologist 
Pharmacist 
Decentralised 
site 
Physiotherapist Social Worker 
Audiologist Dietician 
Occupational 
Therapist 
A further finding was lack of communication of data from one level to the next, “TB 
programme is data driven, therefore, we need to ensure the integrity and the validity of 
the data and it usually starts at facility level… we do not have the electronic DR system 
at the facility’…when the data capturer at the decentralised site need to capture this 
information and there's all of these fields is not even completed, how difficult it is in then 
to obtain quality data in order for us then to report to the next level” P16 (16:38). Lack 
of the electronic capturing system for MDR-TB at primary health care level thus affects 
the data completeness and quality that is reported to the next level. 
 
4.2.3 Health-care provider factors 
Health-provider factors include the following: staff shortages, staff morale, and fear of 
contracting TB. 
Staff shortages 
The policy recommends a multi-disciplinary team approach including the following 
staffing complement for decentralised sites: 
 
 
Figure 2. Recommended Staffing Complement for the Decentralised MDR-TB Site 
(Source: Adapted from Management of Drug-Resistant Tuberculosis Policy Guidelines, 
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2013). 
However, the study found that the MDR-TB sites were experiencing staff shortages in 
most of the recommended categories of staff according to the policy, specifically, in the 
categories of auxiliary support staff. Furthermore, the study found the following factors 
contributing to the staff shortages experienced: lack of social support staff, posts 
remaining vacant for significant periods of time, ineffective recruitment, loss of clinical 
posts, and an absence of retention strategies. 
Key social support staff was lacking: “We have no social worker…even at PHC level they 
don’t even feel that there’s a social worker support there for them” P16 (5:109). Social 
support is critical in order to ensure a multi-disciplinary approach to holistic care as 
recommended by the Management of Drug-Resistant Tuberculosis Policy Guidelines, (2011: 
16), and staff shortages in this area affect implementation of the decentralisation policy. 
Furthermore, certain posts remained vacant for significant periods of time, “A whole year 
we went by without a physio” P10 (3:74). Longstanding vacant posts among management 
level have resulted in other managers in acting positions rather than permanent posts: 
“I’ve been acting nursing service manager since 2010” P11 (4:202). 
In terms of recruitment processes, concern was expressed that recruitment is slow and 
ineffective with processes still centralised and controlled at provincial level: “When it 
comes to filling of posts, vacant posts, it’s a challenge which really makes us then remain 
with vacancies that are not filled…I cannot advertise that post, it must then be head office 
that approves and actually advertises. Then when it comes to filling of that post, the 
selection part for certain level…then it has to be done here and I can appoint, but even 
that has restrictions now. You cannot appoint, it must first go to Bisho again” P9 (2:99). 
This finding suggests that recruitment of staff has not been decentralised in line with the 
policy. 
In terms of clinical posts, findings suggest that once a person exits a post that position is 
frozen: “Basically they’re not replacing lost post…austerity measures...It’s very difficult 
now, you won’t see any clinical posts really available” P10 (3:73). Recent changes in 
structure of hospital organograms has also resulted in posts being lost, “The organogram 
has taken away a lot of staff members and added on some unnecessary staff members…If 
I speak now just specifically of us, I am not on the organogram…So there’s a lot of like 
uncertainty and unease amongst the staff members with regards to that. So it’s difficult 
also to plan activities also. Because if you know you’re not part of that organogram, it’s 
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difficult really” P10 (4:75). This freezing of posts contributes directly to staff shortages. 
In addition, an absence of retention strategies contributes to staff shortages through high 
turnover of staff, “If you want to get applicants, there are no attractive measures, even 
with our retention, if someone wants to go out and go back to wherever, we don’t have 
retention strategies unlike in private sectors” P13 (1:171). Lack of accommodation and 
better educational opportunities in urban areas were cited as specific areas where retention 
strategies were lacking, “There is no accommodation allowance. There’s no 
accommodation also for the nurses on the premises…those who apply they apply with the 
intention of moving quickly to the urban area. If someone is coming from that side and 
wants to further their education, they will apply because there is a post but few months 
down the line, they will request now a transfer” P13 (1:173). 
Staff morale 
A specific factor among those interviewed was poor staff morale; “It’s staff burn-out, I 
don’t know, because I think they are not motivated because they are already short, they 
feel overwhelmed with their work and so if one was absent last week, so it’s like a payback 
time, I’m also going to be absent so they you can feel the burden that I felt” P13 (1:168). 
When probed further for possible reasons for poor staff attitude it was shared that a lack 
of appreciation by both staff and patients was a contributing factor, and that a negative 
attitude affects patient care; “Attitude of staff members, you know… that really can be, I 
don’t know, disappointing or depressing so to speak… you find out that our staff members 
are not motivated mostly…hence they end up having negative attitudes and of course as 
you can imagine having a negative attitude towards our sickly patient” P2 (10:104). 
One of the participants described a lack of appreciation from both staff and patients as a 
cause of this poor attitude; “I think most of the time what I’ve heard is that they’re 
overloaded with work. Their complaints are not being attended to properly, they don’t 
feel appreciated by the superiors. Now they don’t feel appreciated by the superiors and 
mostly and sometimes by the patients themselves as well” P2 (10:103). 
Fear of contracting TB 
It emerged from the findings that there is fear among health care workers of contracting 
DR-TB; “Immediately they see that patient I’m sure they fear that patient will infect them 
with that DR-TB…now they don’t want to use the N95 mask…, but immediately you say 
I’ve got an MDR, all of them they have that fear of unknown” P8 (9:177).
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When probed about lack of accountability among nurses for managing DR-TB patients; 
“I just think it’s fear” P12 (6:106). “They are afraid of, particularly some nursing staff, 
of admitting patients that are labelled as DR-TB” CM4 (14:79). 
 
4.2.4 Patient-related factors 
Patient-related factors that will be discussed include: Loss to Follow Up, Stigma, and 
social grants of MDR-TB patients. 
Loss to Follow Up 
The findings of the study identified three factors affecting Loss to Follow Up, namely: 
length of stay, lack of understanding the importance of taking medication, and defaulting 
treatment due to pill burden and side effects of treatment. 
Firstly, length of stay was found to be a factor for patients according to study findings, 
Patients don’t want to stay there too long because they’re far away from home, relatives can’t 
come and visit them, so they itch to get out of there. And obviously once they are out of there 
then the defaulting starts really” P10 (3:76). 
Secondly, lack of understanding the importance of taking medication among patients was 
described, “I just think that on the community side it is just more the fact that our people 
just don’t seem to understand health as it is. I have the feeling or they will say if they’re 
sick it’s the nurses or the doctors that must fix it. But from the community side they don’t 
understand that they have to put effort in too. They have to take their medication” P12 
(6:125). 
Thirdly, defaulting treatment due to pill burden and treatment side effects was a factor 
leading to Loss to Follow Up as described by participants, as you know when it comes to 
the DR-TB treatment it’s a lot of tablets that they need to swallow. Some of them will give 
a reason and say, but okay it’s the side effects of the medication, I’ve got nausea and 
vomiting and that is the reason why I don’t take the medication. P18 (16:32). 
Stigma 
Stigma was experienced in both the home and in the public health facility by the patients. 
The following findings suggest stigma experienced in the home, “It’s like now once the 
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patient has been diagnosed as MDR, you find that at home they don’t want to accept the 
patient back. The patient now is supposed to be discharged to finish treatment at home, 
now the family is not willing to take the patient back, now you start to hear all sorts of 
things to say no, it was not my child by the way, it was my aunt’s, the aunt is like, nobody 
wants to take just because of the stigma of being an MDR patient” P11 (4:201). 
Stigmatising factors were masks for infection control and mobile clinic vehicles, “I think 
that’s a thing with patients, it’s stigma, it’s wearing a mask…wearing a mask, having the 
government vehicle in front of their houses…it’s stigmatising them. I told you must phone 
me or come to my work, or don’t come to my workplace, now everybody’s going to ask 
why are you here” P16 (5:104). 
Stigma experienced by the patient within the health facility was also described, “…so that 
stigma to that patient, so that’s why I just go to them [nurses], please people, this is a 
patient, a human being and is having a disease that will have next time even you yourself, 
even your brother or sister, it’s a human being. So you must treat them same thing and 
then they said, it’s your job to do all this” P8 (9:193). 
Social grants for MDR-TB patients 
Aligned to the rights of the constitution, the MDR-TB decentralisation policy (2011) 
refers to the Social Assistance Act 13 of 2004 as providing a framework for social 
assistance where necessary for all patients that are diagnosed with MDR-TB. Thus, 
following an assessment by a clinician, MDR-TB patients are eligible for a temporary 
disability grant. 
However, a further patient-related factor identified was that of social grants being used to 
buy alcohol, “Alcohol abuse, it’s a big, big, big thing. People would use their grants… 
we don’t even go out during the first week of every month after grants pay-outs. Because 
you know, you’re either getting them drunk, you won’t get them, there will be issues when 
you get there” P16 (5:78). Findings described alcohol abuse occurring even in the 
hospital, “They abuse alcohol inside the hospital. The police has made many turns here. 
They take them then they sleep until they are sober, then they bring them back” P15 
(15:110).  
Findings also suggest a link between misuse of grants and poor treatment outcomes, “And 
now people being people, some of them instead of buying food with this grant, go and buy 
alcohol and then they don’t come to the clinics to get their treatments. That is a major 
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challenge which is causing default or stopping of treatment and ultimately leading 
patients to becoming sick and then they have to be hospitalised at a later stage and then 
most of them, they don’t survive, they die” P14 (14:76). 
In summary, roles and responsibilities have been discussed, specifically how the ascribed 
and actual roles differ. In addition, factors influencing implementation of decentralisation 
of the MDR-TB policy have been presented and include: operational, health system, 
health provider, and patient-related factors. The following chapter will discuss the 
findings. 
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5. DISCUSSION 
 
The discussion focuses on unpacking the challenges emanating from the findings of the 
study: roles and responsibilities; holistic approach to integrated care within a specialist 
vertical programme; poor staff morale; poor alignment of non-governmental 
organisations (NGOs) to government health services; lack of knowledge of multidrug- 
resistant tuberculosis (MDR-TB) amongst private health care (PHC) clinic supervisors; 
lack of retention in care of HIV positive patients impacting on TB burden; lack of 
communication between reporting structures at different levels of health care; and finally, 
stigma experienced by the patient in the community. 
Regarding the implementation of the MDR-TB decentralisation policy, there was a 
mismatch between practice and policy in terms of roles and responsibilities. The study 
found that traditional roles and responsibilities were hindered due to lack of availability 
of the complement of staff to support a multi-disciplinary approach. In addition, key role 
players were expected to assume additional responsibilities to those defined in the MDR- 
TB Decentralisation Policy (2011). This is similar to findings with the exploration of 
health care workers’ challenges in the rollout of antiretroviral therapy in Nelson Mandela 
Bay Metropolitan District in the Eastern Cape, where it was found that there was a lack 
of a full complement of staff to perform the tasks required (Williams, van Rooyen & 
Ricks, 2018). 
The findings of this study not only found a mismatch between the staff that was supposed 
to be there according to the policy and who were actually on the staff establishment, but 
also that task shifting had to be implemented to address the lack of the full complement 
of the staff. Interestingly, it has been found that managing health care utilising vertical 
health programmes has often resulted in the lack of clarity about certain responsibilities 
and lines of accountability created during the decentralisation process (McIntyre & 
Klugman, 2003). However, decentralisation of health services using a task shifting rather 
than task sharing approach, with shifting of responsibilities from medical to professional 
nurses and community health workers, not only increased access to antiretroviral therapy 
(ART) for patients but has also increased the workload of nurses (Williams, van Rooyen 
& Ricks, 2018). 
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Bedelu et al (2007) also showed similar findings with the provision of a decentralised 
approach to provision of antiretroviral services at primary health care level resulting in 
task shifting due to a significant increase in the number of patients accessing services. 
Despite utilisation of clinic services almost doubling over a two-year period (from 16,465 
service users in April 2004 to 28,191 service users in April 2006), the number of 
professional nurses did not increase, and task shifting was an inevitable consequence of 
this significant increase in workload (Bedelu et al, 2007). The traditional role of the nurse 
would include the following key responsibilities: support of the physician, conducting 
Voluntary Testing and Counselling (VCT), ensuring readiness of patients for ART and 
supervising community caregivers. However, in this task shifting approach (Bedelu et al, 
2007), the nurses’ responsibilities included the following: management of opportunistic 
infections, performing clinical staging of HIV positive patients, initiation and monitoring 
of ART, supervision of clinic staff, and supervision of adherence counsellors, 
responsibilities that would traditionally fall under the role of the clinician (Bedelu et al, 
2007). 
Although not a finding of this study, the evidence in the literature suggests that 
decentralisation of MDR-TB services results in improved coverage and satisfactory 
treatment outcomes without compromising quality of care (Loveday et al, 2018). In 
order to achieve this, a holistic multi-disciplinary approach to patients treated for MDR-
TB is recommended in the MDR-TB decentralisation policy (2011). Findings from this 
study, however, showed that implementing a horizontal, holistic approach to integrated 
care within a specialist vertical programme was a challenge. This finding is similar to 
evidence that a multi-disciplinary approach to patients provides equivalent clinical 
outcomes as well as improved disease control and service delivery, although there are 
challenges in achieving integrated multi- disciplinary care between specialist services 
and primary care (Mitchell et al, 2015). Mounier-Jack, Mayhew & Mays (2017) 
concurred when they found that in resource- constrained settings there was a 
discrepancy between approaches in local health care systems, which focus on vertical 
disease-specific programmes, and a horizontal, integrated approach where patients are 
managed with comorbidities and/or complex health needs. 
This study found that the staff appears to have poor morale. The staff specifically 
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accounted their poor morale to being overloaded with work. A healthy morale among the 
workforce is deemed an important component in the work environment. Managers often 
focus on productivity while neglecting staff morale, despite output of employees being 
dependent on staff morale (Matsaung, 2014). Similarly, workload was reported as one of 
the factors that affected motivation and job satisfaction (Bonenberger et al, 2014; 
Matsaung, 2014). In addition to workload, other factors included organisational 
commitment, satisfaction with management, and career development (Bonenberger et al, 
2014). 
The implementation of ward-based outreach teams (WBOTs) is one of the key 
interventions of the South African National Department of Health’s (NDoH) Primary 
Health Care re-engineering (rPHC) strategy for improving health outcomes (Pillay, 2010). 
However, a finding of this study was that aligning NGO activities to government health 
ward-based outreach teams, is difficult. There is similar evidence in the literature, where 
a study by Austin-Evelyn et al (2018) reports the lack of alignment between services 
provided by government-employed and NGO-funded CHWs operating at the same level 
of care, i.e. ward-based outreach teams where government-employed CHWs felt that they 
were competing with CHWs funded by more vertical disease-specific projects run by 
NGOs (Austin-Evelyn et al, 2018). 
Another challenge for alignment found in this study is the lack of knowledge of MDR- 
TB among the PHC clinic supervisors. This was similar to findings in the Eastern Cape 
Province, where the knowledge levels of nurses on MDR-TB working at TB units in PHC 
facilities were assessed and it was found that less than 40 % of PHC nurses had been 
trained on MDR-TB in comparison to 91 % who had received training on HIV/AIDS 
(Singh & Janse van Rensburg, 2014). The authors also found that the study participants’ 
rating of their knowledge to manage patients with MDR-TB showed that 59 % felt that 
they lacked knowledge in providing MDR-TB treatment, while 79 % felt that they did not 
have enough knowledge to monitor side effects of treatment. Moreover, in India, an 
assessment of the knowledge of TB among four hundred nurses found that the knowledge 
of treatment of MDR-TB (63 %) was lower than knowledge on drug susceptible TB (73 
%) (Kansal et al, 2014). 
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This research found that if HIV-positive patients are not retained in care it is perceived to 
affect the TB caseloads. This is supported in the literature where it has been shown that 
reduced immunity due to HIV infection puts patients at higher risk of developing 
opportunistic infections such as TB than patients who are HIV-negative (Carlsson et al, 
2014). In Nigeria, the incidence and predictors of tuberculosis among HIV-infected adults 
showed that sub-optimal ART adherence led to a higher incidence of TB (Pathmanathan 
et al, 2017). In South Africa, the lack of HIV viral suppression (viral load 10,000 copies 
per ml) was associated with a 2.5-fold increased adjusted hazard of TB (Van Rie et al, 
2011). 
In addition, in terms of treatment outcomes, a lack of alignment of TB and HIV 
programmes could result in HIV patients not being retained on ART, leading to an 
increased mortality from MDR-TB. A study assessing risk factors for mortality among 
MDR-TB patients in the Eastern Cape Province found that HIV co-infected patients who 
don’t receive ART, are at significantly higher risks of mortality (adjusted incidence risk 
ratio 3.3, 95 % confidence interval 2.9-3.8) (Chingonzoh et al, 2018). Similar findings 
were observed in a study by Nglazi et al (2015), where it was found that if not properly 
managed and retained in care, HIV-positive TB patients are a challenge to TB services 
since they may have poorer TB treatment outcomes. 
This study found that there was a lack of communication between reporting structures at 
the different levels of care. Firstly, TB is a data-driven programme, and that the need to 
ensure integrity and validity of data starts at facility level. However, the data entry point 
for MDR-TB is at the decentralised site, resulting in many incomplete fields when the 
data capturer attempts to enter the relevant data. This is mainly due to the fact that the 
electronic drug-resistant tuberculosis register (EDRWeb) is not available at PHC level but 
only at the decentralised sites, which impacts on the data quality that is communicated 
between PHC-level and decentralised-level in the same district. Data management 
challenges in TB have been highlighted in the literature and include challenges with 
tracking of patients who have transferred to another district or sub-district (Churchyard et 
al, 2014). 
Further evidence shows that there is a lack of communication and integration of data 
between different programmes at the same operational level (Page-Shipp et al, 2012). 
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However, there are ongoing efforts by the National Department of Health to integrate data 
systems at primary health care level, with the ideal of a fully integrated data management 
system adopting the approach of one patient, one appointment, one file, and one data 
management system (Naidoo et al, 2017). Page-Shipp et al (2012) argues that the gaps 
that have been observed with regard to data completeness at the same level of care, in this 
case lack of ART documentation in the TB register or on the TB treatment card. This 
indicates that incomplete ART data will be recorded in the TB data recording systems, 
resulting in poor data completeness and quality when reported to the next level. 
In terms of patient-related factors, this study found that stigma experienced by the patient 
both in the home and in the public health facility was a key factor influencing the 
successful completion of MDR-TB treatment. With regard to stigma within the home and 
community, this study found that once the patient has been diagnosed with MDR-TB, it 
is difficult to discharge the patient back into the community due to resistance from the 
family in accepting the patient back home. This finding was similar to a study in Malawi, 
where stigma and discrimination was experienced by the patient in the community 
(Nyasulu et al, 2018). However, evidence in the literature has shown that the stigma was 
due to the association of HIV with TB, rather than due to TB itself (Nyasulu et al, 2018). 
Furthermore, a study within the Eastern Cape Province in South Africa found that the 
stigma associated with TB in the past was due to the perception that it was an incurable 
disease, but that it lost its stigma in the community when the message of TB being a 
curable disease was acknowledged (Moller & Erstad, 2012). 
A study in Uganda demonstrated that home-based care rather than a hospital-based 
approach was preferable, and that community members were positive about patients being 
treated in the community (Horter et al, 2014). There were no reports of stigma due to 
MDR-TB itself, and no respondents expressed a fear of MDR-TB transmission to 
themselves or others due to patients being treated at home or in the community (Horter et 
al, 2014). 
In summary, there is a mismatch in roles and responsibilities in terms of alignment to 
those described in the MDR-TB Decentralisation Policy (2011). Challenges in providing 
a holistic approach to integrated care within a specialist vertical programme were 
reported. The staff appears to have poor morale as a consequence of heavy workload. In 
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addition, aligning NGO activities to government health, ward-based outreach teams were 
found to be difficult. Another challenge in terms of alignment found in this study is the 
lack of knowledge of MDR-TB among the PHC clinic supervisors. This research found 
that if HIV positive patients are not retained in care, it is perceived to affect the TB 
caseloads. Regarding communication between different levels of care, there was a lack of 
communication between reporting structures. With regard to patient-related factors, 
stigma in the home and community was an issue and once the patient has been diagnosed 
with MDR-TB, it is difficult to discharge the patient back into the community. 
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6. CONCLUSIONS AND 
RECOMMENDATIONS 
 
6.1 Conclusion 
The aim of the study was to explore and describe the factors influencing the roles and 
responsibilities in the decentralisation of MDR-TB services in decentralised MDR-TB 
sites from a management perspective. The study found when comparing the actual and 
ascribed roles and responsibilities of facility level decentralised site management teams 
(DSMTs) that firstly, there is task shifting with the site staff taking on additional 
responsibilities to those defined in the MDR-TB decentralisation policy (2011). The 
additional responsibility can be ascribed to the fact that the decentralised site has not 
acquired the compliment of staff required to support a multi-disciplinary approach, both 
within the site and the district. Secondly, staff shortages and poor staff morale were 
experienced which led to the perception of overloaded with responsibilities and were 
found to be significant factors hindering the implementation of service delivery. Thirdly, 
the lack of knowledge of MDR-TB amongst PHC supervisors influenced the roles and 
responsibilities of the staff at the decentralised MDR-TB sites, whereby they were 
required to take on the additional role of mentoring of PHC nurses. 
Finally, providing a holistic approach to integrated care within a specialist vertical 
programme was found to be very challenging, hindering implementation of 
decentralisation. The lack of alignment of NGO support with governmental services was 
identified as one of the key hindering factors. In addition, a lack of integration of TB and 
HIV, specifically the challenge of retention of HIV positive patients on ART, influenced 
the TB caseload. Furthermore, lack of access to EDRWeb at PHC clinics makes 
communication of data from PHC level to decentralised sites a challenge. 
 
6.2 Recommendations 
Based on the findings of this study, the following recommendations are made: 
 Eastern Cape Department of Health should decentralise Human Resources to 
district level in order to improve staff recruitment for vacant posts and retention 
strategies. 
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 Inter-sectoral platforms should be strengthened to ensure that NGO support is 
aligned to the needs of the programme and providing services along the continuum of 
care, rather than focusing on specific interventions that only speak to certain aspects of care. 
 The Provincial Department of Health should focus on strengthening of TB and 
HIV integration at all points of care by strengthening rPHC rather than a vertical 
approach. 
 Retention on ART of HIV positive patients should be a key area to focus. 
 The National Department of Health’s Research, Implementation, Monitoring and 
Evaluation Division should ensure that communication of data should is available 
through inter-operable systems between PHC clinics and decentralised sites. 
 The district should provide training and mentoring for PHC nurses and supervisors 
on MDR-TB in addition to drug susceptible TB and HIV. This training should 
include the basics of MDR-TB, allowing the decentralised sites to discharge 
uncomplicated MDR-TB patients to PHC clinics. 
 Community mobilisation led by community-based organisations should focus on 
stigma reduction training rather than focusing only on training on TB/ HIV for 
patient families and the community. 
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Appendix 1: Interview Guide Chief Executive Officer 
 
 What is your job title? 
 How long have you been working in this position? 
 What is your tertiary qualification? 
 Have you received any additional formal or informal training? 
 Can you please describe the role you perform in the hospital? 
 What is different from the way you performed your responsibilities before? 
 What are your key areas of responsibilities? 
a. In terms of: ensuring effective financial accountability – describe your role in 
effective monitoring of expenditure. How often are finance meetings held? 
Describe the process of submission of financial reports. Do you keep a commitment 
and accrual register? How do you monitor that suppliers are paid within thirty days 
of receiving an invoice? With regard to your role in ensuring financial 
accountability, do you experience any challenges? 
b. Effective implementation of the strategy primary health care (PHC) restructuring? 
How do you facilitate the implementation of PHC restructuring with regard to 
improving reporting on the following: 
i. supervision 
ii. ward based teams 
iii. district clinical specialists 
iv. school health 
e. How are outreach programs used to ensure integration of service delivery in the 
sub district and what is your role in this activity? Do you experience any 
challenges in ensuring effective implementation of PHC restructuring? 
f. Effective evaluation and capacitation of all staff – describe the process of 
evaluation of all staff and your role in this process. How do you ensure 
capacitation of hospital staff in team building, managerial skills and change 
management in order to improve hospital service delivery and management? Do 
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you experience any challenges in this role? 
g. Improving and strengthening planning through integrated alignment of district 
health plans with Annual Performance Plans and Operational Plans – describe 
your role in ensuring that plans are aligned. How is implementation of work 
plans monitored? How regularly is it monitored? Do you experience challenges in this 
activity? 
h. Ensuring that effective employment practices are in place that enable adequate 
and timeous Human Resource coverage – describe this process and your role in 
this. 
i. To ensure provision of an effective, acceptable, accessible, qualitative legal health 
service relevant to specialised TB hospital care – what is your role in ensuring a 
core package as per National and Provincial Policies and legislation including the 
following: 
i. infection control 
ii. availability of cleaning materials 
iii. food services 
iv. laundry services 
j. Do you experience any challenges in this role? 
k. Is there any key activity that you perform that we have not mentioned? Please 
describe. 
 What is your management role specifically? Do you have any subordinates? How 
many? 
 Can you describe your role in decision-making regarding MDR-TB health services? 
Are you satisfied with your role? Do you feel that this role allows you to perform the 
responsibilities you have been given? 
 Do you experience any other challenges that have not been mentioned before? 
 Now that we spoke about what is challenging, tell me what is working and what is 
working well? 
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Appendix 2: Interview Guide Nursing Services Manager 
 
 What is your job title? 
 How long have you been working in this position? 
 What is your tertiary qualification? 
 Have you received any additional formal or informal training? 
 Can you please describe the role you perform in the hospital? 
 What is different from the way you performed your responsibilities before? 
 What are your key areas of responsibilities? 
a. In terms of: ensuring linkages with other stakeholders that provide services to 
the decentralised MDR-TB site specifically relating to patient management and 
care – what helps you or prevent you from being able to ensure that linkages 
take place? What are the difficulties in establishing and maintaining these 
linkages? 
b. Tracing of newly diagnosed MDR-TB patients – Describe the process in terms 
of who it involves and the role you perform in it? Do you experience any 
challenges with tracing patients? Do you experience any challenges in 
coordinating activities of tracing team and monitoring their activities? How do 
you monitor the team’s tracing activities? How often do you monitor? 
c. Organising monthly clinical reviews of MDR-TB patients on treatment – Does 
the review happen on monthly basis? Who attends these reviews? Do you have 
the information at the meeting to discuss? What is the quality of the 
information? 
d. How do you ensure recording and reporting procedures are up to date? Who 
records the information and where? What is your role in the process? 
e. Do you experience any challenges with mobilising the mobile injection teams 
to ensure that injections are given to outpatients timeously? What have you done 
to address these challenges? 
f. Is there any key activity that you perform that we have not mentioned? Please 
describe. 
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 What is your management role specifically? Do you have any subordinates? How 
many? 
 Can you describe your role in decision-making regarding MDR-TB health services? 
Are you satisfied with your role? Do you feel that this role allows you to perform the 
responsibilities you have been given? 
 Do you experience any other challenges that have not been mentioned before? 
 Now that we spoke about what is challenging, tell me what is working and what is 
working well? 
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Appendix 3: Interview Guide Clinical Manager 
 
What is your job title? 
 How long have you been working in this position? 
 What is your tertiary qualification? 
 Have you received any additional formal or informal training? 
 Can you please describe the role you perform in the hospital? 
 What is different from the way you performed your responsibilities before? 
 What are your key areas of responsibilities? 
a. In terms of ensuring that the clinical team assesses patients for co-morbidities 
and that appropriate baseline tests are requested – describe the process of who 
this involves and your role in it. 
i. Do you experience any challenges in coordinating this activity? 
ii. How do you monitor the clinical team’s activities in carrying out this 
function? 
b.  Ensuring patient clinical management is monitored - describe the process in 
terms of who it involves and the role you perform in it. Do you experience any 
challenges with coordinating this function? 
i. How do you monitor the clinical team’s patient clinical management 
activities? 
ii. Do you experience any challenges in monitoring this function? 
iii. How often do you monitor? 
c. Ensuring that adverse drug reactions are monitored, reported and managed 
appropriately – describe the process in terms of who it involves and the role 
you perform in it. 
i. Do you experience any challenges with coordinating this function? 
d. How do you monitor the clinical team’s patient clinical management 
activities? 
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i. Do you experience any challenges in monitoring this function? 
ii. How often do you monitor? 
e. Ensuring that patients at the decentralised MDR-TB site that are identified as 
requiring specialist care are up-referred – describe the process in terms of who 
is involved at the different levels of care and define your role in this referral 
process. 
i. Do you experience any challenges in coordinating this function? 
ii. Do you have meetings with the different stakeholders regarding 
referral pathways? 
iii. How often do these meetings take place? 
f. Is there any key activity that you perform that we have not mentioned? Please 
describe 
 What is your management role specifically? Do you have any subordinates? How 
many? 
 Can you describe your role in decision-making regarding MDR-TB health services? 
Are you satisfied with your role? Do you feel that this role allows you to perform the 
responsibilities you have been given? 
 Do you experience any other challenges that have not been mentioned before? 
 Now that we spoke about what is challenging, tell me what is working and what is 
working well? 
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Appendix 4 : Interview Guide DR-TB Focal Nurse 
 
 What is your job title? 
 How long have you been working in this position? 
 What is your tertiary qualification? 
 Have you received any additional formal or informal training? 
 Can you please describe the role you perform in the hospital? 
 What is different from the way you performed your responsibilities before? 
 What are your key areas of responsibilities? 
a. In terms of: coordinating clinical care with other health professionals, 
including counsellors and pharmacist - describe the process in terms of who it 
involves and the role you perform in it. 
i. Do you experience any challenges with this role? 
ii. How do you monitor the coordination of clinical care with other health 
professionals? 
iii. How often do you monitor? 
b. Ensuring patients are referred to the doctor where necessary – describe the 
referral pathways and the role you perform in it. 
i. Do you experience any challenges with this role? 
ii. How do you monitor patient referrals? 
c. Coordination of household assessments, discharge of patient and linkages to 
outpatient services - describe the process in terms of what it involves and the 
role you perform in it? 
i. How are NGO/Community-based Organisations (CBO) linkages 
coordinated? 
ii. Do you experience any challenges with this role? 
d. Management of the outpatient clinic activities – describe the process in terms 
of what it involves and the role you perform in it? 
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i. Do you experience any challenges with this role? 
e. Overseeing educational talks for patients and relatives – describe the process 
in terms of what it involves and the role you perform in it? 
i. Do you experience any challenges with this role? 
f. Is there any key activity that you perform that we have not mentioned? Please 
describe. 
 What is your management role specifically? Do you have any subordinates? How 
many? 
 Can you describe your role in decision-making regarding MDR-TB health services? 
Are you satisfied with your role? Do you feel that this role allows you to perform the 
responsibilities you have been given? 
 Do you experience any other challenges that have not been mentioned before? 
 Now that we spoke about what is challenging, tell me what is working and what is 
working well? 
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Appendix 5: Interview Guide District Manager (HIV & AIDS, STI and TB (HAST) Manager 
or district TB/sub-district TB coordinator) 
 What is your job title? 
 How long have you been working in this position? 
 What is your tertiary qualification? 
 Have you received any additional formal or informal training? 
 Can you please describe the role you perform in the hospital? 
 What is different from the way you performed your responsibilities before? 
 What are your key areas of responsibilities? 
a. In terms of: ensuring that all confirmed MDR-TB patients are referred to the 
MDR-TB hospital - describe the process in terms of what it involves and the 
role you perform in it. 
i. Do you experience any challenges in tracing MDR-TB patients? 
ii. How do you ensure that all newly-diagnosed MDR-TB patients are 
traced and linked to care? 
iii. How do you monitor this process? 
b. Ensure availability of drugs for the patient at the clinic or district hospital – 
describe the process in terms of what it involves and the role you perform it. 
i. Do you experience any challenges in supply chain management? 
ii. How do you monitor drug stock outs? 
c. Establish an efficient patient retrieval system for patients who default MDR- 
TB treatment. 
i. Who records the information and where? 
ii. What is your role in the process? 
d. Arrange transportation for patient evaluation and follow-up at the MDR-TB 
site – describe the process and the role you perform in it. Do you experience 
any challenges? 
i. How frequently are patients evaluated at the MDR-TB site? 
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ii. How do you monitor attendance of patients for evaluation and follow 
ups? 
e. Appoint disease outbreak teams to conduct contact screening programmes for 
all close contacts of confirmed MDR-TB patients six monthly for two years – 
describe the process in terms of what it involves and the role you perform in it. 
i. Do you experience any challenges? 
ii. How do you ensure that recording and reporting by the teams is fed 
back to the district? 
f. Conduct household assessments prior to discharging patients from MDR-TB 
units - describe the process in terms of what it involves and the role you 
perform in it. 
g. Monitor and evaluate MDR-TB programme performance – How is the MDR- 
TB programme monitored? 
i. At what intervals? 
ii. Who is responsible for monitoring? 
iii. How is the MDR-TB programme evaluated? 
iv. Are external stakeholders involved in monitoring and evaluation? 
v. Do you experience any challenges in this role? 
h. Ensure continuum of care for patients post discharge - describe the process in 
terms of what it involves and the role you perform in it. 
i. Ensure ongoing psychosocial support for patients – describe the linkages that 
are available with other stakeholders including social services. 
i. Do you have regular meetings to discuss psycho-social support? 
ii. How often do you meet and who attends these meetings? 
j. Increase awareness and education about MDR-TB among communities – 
describe the linkages that are available with other stakeholders such as 
community mobilisation, education and clinic committees. 
i. Do you have regular meetings to discuss community mobilisation? 
ii. If so, how often and who attends these meetings? 
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k. Is there any key activity that you perform that we have not mentioned? Please 
describe 
 What is your management role specifically? Do you have any subordinates? How 
many? 
 Can you describe your role in decision-making regarding MDR-TB health services? 
Are you satisfied with your role? Do you feel that this role allows you to perform the 
responsibilities you have been given? 
 Do you experience any other challenges that have not been mentioned before? 
 Now that we spoke about what is challenging, tell me what is working and what is 
working well 
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Appendix 6: Comparison between actual and ascribed roles of staff at decentralised MDR TB sites 
Staff 
category 
Actual role Ascribed role Comparison 
CEO Resource management (including human 
resource, material and financial) for 
implementation of those policies, not only 
the decentralisation policy but also 
infection control and national core 
standards policies. 
 
Oversight of the various multi- 
disciplinary team committees within the 
site. 
 
Reporting of monthly expenditure to 
Budget Advisory Committee Meeting. 
 
Management stakeholder communication 
Develop appropriate strategic and 
operational plans and budgets. 
 
Provide oversight of the highest quality 
clinical and non-clinical services. 
 
Ensure regular collection, evaluation and 
reporting of high-quality data on services 
provided. 
 
Manage staff and budget. 
 
 
Liaise with cluster managers, hospital 
boards and community groups as well as 
In general, there is a similarity in the 
actual and ascribed roles of the CEO as 
described in the findings. 
 
However, findings from the actual role 
suggest that in addition to the 
decentralisation policy, there are other 
policies including infection control and 
national core standards policies that are 
not mentioned in the ascribed role. Whilst 
there is some overlap of these policies 
with the decentralisation policy, 
additional responsibilities are expected 
with additional policies to be adhered to. 
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including district/ provincial and public 
engagement through the hospital board. 
other district hospitals. 
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 Provision of oversight of linkage within 
district and outreach programmes to 
ensure integration of service delivery at 
primary health care level. 
  
Clinical 
Manager 
Oversight and coordination of the clinical 
component of staff, including doctors, 
pharmacists, social workers, 
radiographers, occupational therapists and 
audiologists. 
 
Ensuring quality of clinical care through 
adherence to guidelines with regard to 
treatment regimens, regular monitoring 
(laboratory) and side effect management. 
 
Oversight of pharmacovigilance. 
Management of clinical services budget. 
Assess patient for co-morbidities and 
request baseline tests. 
 
Initiate DR-TB treatment. 
Monitor patient clinically and adjust 
treatment where necessary. 
 
Report adverse drug reactions to 
Medicines Control Council. 
 
Provide prompt referral for tertiary or 
specialist care where necessary. 
The actual and ascribed roles are similar. 
In addition to oversight of clinical 
services, the actual role of the Clinical 
Manager includes management of the 
clinical budget not mentioned in the 
ascribed role. 
 
Findings also suggest that the Clinical 
Manager is expected to sit on various non- 
clinical committees including skills 
development, complaints and 
accommodation committees. Participation 
on these committees is not mentioned 
under ascribed roles. 
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Ensure regular monitoring through 
laboratory testing is done timeously. 
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 Non-clinical responsibilities include role 
within various committees, including 
skills development, complaints and 
accommodation committees. 
Educate nurses and other members of 
team. 
 
Nursing 
Services 
Manager 
Providing supervisory role from 
diagnosis, admission, monitoring of the 
patient and show that the correct treatment 
is given according to the regimen and that 
regular monitoring is performed. 
 
Ensuring monthly follow up of patient. 
 
 
Ensuring those patients on injectable 
phase of treatment have the necessary 
audiometry testing to exclude drug- 
induced hearing loss. 
Liaise with mobile teams and staff at 
facilities administering DR-TB treatment. 
 
Ensure recording and reporting 
procedures are up to date. 
 
Liaise with other stakeholders in the 
geographical area. 
 
Organise and document six-monthly 
contact screening. 
 
In addition to the ascribed role, the actual 
role of the Nursing Services Manger 
includes ensuring those patients on 
injectable phase of treatment have the 
necessary audiometry testing to exclude 
drug-induced hearing loss. 
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Supervision of nursing staff in monitoring 
of all adverse events and ensuring 
adequate intervention through 
Trace newly-diagnosed DR-TB patients 
and facilitate linkage to care and 
admission if necessary. 
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 communication with the clinicians as well 
as the multi-disciplinary team including 
audiology, clinician, social worker. 
 
Facilitating stakeholder engagement, 
including NGO support, in order for 
patients to receive the necessary support 
in completing treatment once discharged 
into the community. 
Arrange regular monthly visits for 
outpatients at decentralised sites. 
Coordinate and monitor tracing team 
activities. 
 
Focal 
DR-TB 
Nurse 
Providing support as outreach nurse, 
doing reviews at the clinics in the 
catchment area for that specific 
decentralised site. 
 
Providing mentoring on DR-TB 
management for primary health care 
nurses. 
 
Monitor inpatients and refer to doctor 
where necessary. 
 
Coordinate household assessment, 
discharge and linkage to outpatient 
services. 
 
Manage weekly outpatient clinic. 
In addition to the ascribed roles of the 
Focal DR TB nurse, findings suggested 
that the Focal DR TB nurse is expected to 
provide mentoring on DR-TB 
management for primary health care 
nurses. This additional activity, as 
previously discussed, should fall under the 
responsibility of the district and not the 
decentralised MDR TB site. 
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Liaising with the pharmacists and ensure 
that the patient understands the 
 
 
Support nursing staff. 
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 medication and side effects, and that side 
effects are managed and reported. 
 
Participating in home visits to the newly 
diagnosed TB patients’ homes to assess 
social issues and infection control and 
establishing a support system for 
discharge. 
 
Doing home visits to patients who are 
interrupting treatment and provide 
counselling. 
 
To educate and screen family members. 
 
 
To provide the linkage for clinical support 
Monitor electronic Drug Resistant TB 
register (EDRWeb) and compile six- 
month reports. 
 
Provide Voluntary Testing and 
Counselling (VCT) for HIV. 
 
Provide educational talks to patients. 
 
 
Ensure paper-based MDR-TB register is 
updated regularly. 
 
Ensure patients who miss appointments 
are followed up by tracing team. 
 
With regard to HIV services, the role of 
the Focal DR TB nurse is not only to 
ensure VCT (ascribed role) but also 
ensure linkage for clinical support of the 
HIV programme in order to ensure 
continuity of care (actual role). 
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of the HIV programme. 
 
To ensure timeous updating of records of 
both the patient folders and the registers. 
Liaise with mobile teams with regard to 
patient management. 
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